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Abstract 
 
KEVIN R. RAMKISSOON:  Integrated Top-down and Bottom-up Mass Spectrometry 
Characterization of Escherichia coli Ribosomal Protein Heterogeneity - Identification of 
Protein Isoforms and Post-translational Modifications 
(Under the direction of Morgan C. Giddings) 
 
 The bacterial genome exhibits notable plasticity but is relatively static when 
compared to the proteome. Protein expression can vary significantly depending on 
environmental factors, growth stage or stochastic processes within cells. This highly 
variable character, coupled with the large dynamic range of protein expression levels and 
the complexity achieved through processes such as post-translational modification 
(PTM), necessitate accurate, sensitive and high-throughput methods of analysis. The 
primary aim of this research was to develop an integrated experimental and analysis 
workflow that combines the analytical power of top-down and bottom-up mass 
spectrometry towards protein isoform and PTM characterization. We apply this approach 
to a comprehensive characterization of Escherichia coli ribosomal protein isoform 
heterogeneity. Our findings uncovered a significant level of heterogeneity in the post-
translational modification of a number of ribosomal proteins, revealing a possible 
mechanism for the regulation of ribosomal protein function both within and beyond the 
ribosome. 
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Chapter 1 
Introduction 
 
1.1 Bacterial Phenotypic Heterogeneity 
 Pathogenic bacteria are responsible for significant human morbidity and mortality 
across a broad spectrum of infectious human diseases including tuberculosis, diarrheal 
diseases and lower respiratory infections - amongst the top ten causes of death worldwide 
according to the World Health Organization. The plasticity of bacterial genotypes and 
phenotypes is one of the biggest contributors to their tremendous successes in 
pathogenesis, immune system evasion and their increasing tolerance to antibiotics1-3, 4-8. 
The first and critical step towards solving many of the challenges posed by bacterial 
pathogens is understanding the nature of their complex and highly variable physiology. 
Heterogeneity within bacterial populations can be achieved through a number of 
mechanisms, which can be broadly divided into genetically-based or phenotypically-
based heterogeneity. Phenotypic heterogeneity refers to the observed phenomenon 
wherein individual cells within an isogenic bacterial population achieve different 
phenotypes whilst exposed to the same environmental conditions9. As with genetic 
heterogeneity, phenotypic heterogeneity enhances the overall fitness of a population and 
may sometimes be heritable10. On the level of an individual cell, changes in a bacteria's 
phenotype may be the result of stochastic mechanisms or may occur in response to
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environmental changes, such as may be encountered during growth or pathogenesis. 
Mechanisms such as positive feedback regulation of gene expression, bi-/multi-stable 
gene networks or variable protein post-translational modification have all been shown to 
be mechanisms employed by cells in altering their phenotype11, 12; (figure 1.1). The 
results may be localized to a specific pathway or cellular function (eg. competence)13, or 
alternatively result in global physiological changes (eg. sporulation)14. Regardless of the 
mechanism employed, in the vast majority of cases, the underlying ultimate step of any 
phenotypic change occurs at the level of protein expression and/or post-translational 
modification, hence making the analysis of expressed proteins a key element of any 
examination of bacterial heterogeneity. 
1.2 The Era of the 'omics' 
Over the last two decades or so there have been fundamental changes in the approaches 
to understanding bacterial physiology. The genomics era yielded a tremendous amount of 
information on, and insight into, the genetic makeup of bacteria. As important as the 
organisms that have been sequenced thus far, the technologies that emerged from the 
genomic revolution facilitated the advent of high-throughput DNA sequencing, assuring 
the influx of bacterial genome sequences will continue. Genome sequences provide a 
virtual blueprint of cellular components but provide little to no information on which 
genes are expressed or when. With the determination of DNA sequence no longer a 
bottleneck in the process of bacterial characterization, and with the challenge of decoding 
the meaningful information contained in the vast amount of sequences in hand mounting, 
science turned towards more global approaches to characterizing bacteria. The disciplines 
of transcriptomics, functional genomics and proteomics came to the fro in an almost 
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natural scientific evolution to begin to address the pressing "which?", "whens?", and 
"hows?" of bacterial gene and protein expression. Each of these fields take a global 
approach to the study of organisms by attempting to analyze the full complement, or 
large subsets thereof, of the mRNA transcripts (transcriptome) and proteins (proteome) 
produced by an organism under given conditions15-18. Unlike the more reductionist 
single-gene or pathway-focused studies, such global, high-throughput techniques have a 
much greater potential to identify gene and protein networks that may act in concert to 
engender phenotypic changes in bacteria. Such methods are however accompanied by 
significant challenges, particularly in the management, integration and interpretation of 
the vast amount of data generated. 
1.3 Proteomics  
The term 'proteome' was coined to describe the set of proteins encoded by a study of the 
complement of proteins expressed by a cell, tissue or organism. The field’s overall goal is 
not simply to identify which proteins are expressed, but to fully characterize their 
expression, localization, structure and interactions towards the elucidation their 
functional significance to cellular survival19. Proteins are responsible for the majority of 
the biochemical processes in cells, making the ability to identify and characterize those 
associated with particular cellular phenotypes of critical importance. Traditional 
approaches to protein characterization have focused on single proteins and pathways, or a 
small family of related proteins at a time. 
 While invaluable to understanding prokaryotic biology, traditional techniques such 
as 1- dimensional polyacrylamide gel electrophoresis (1-D PAGE) and western blotting 
are not well suited to high-throughput protein analyses. One of the key limitations faced 
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by protein or pathway-focused studies is that context may sometimes be lost as in many 
cases simultaneous or sequential changes in the expression, localization or activation of 
multiple, often functionally unrelated proteins, are involved in effecting phenotypic 
change. 
The advantages to a more global approach like gene expression profiling or 
proteome analysis stem from an enhanced ability to discern cell-wide patterns in protein 
expression, modification, regulation and interactions, allowing the elucidation of 
intracellular dynamics that may not be apparent from the analysis of proteins or pathways 
in isolation. However as is often the case, a greater potential for finding answers comes 
with greater challenges. 
1.3.1 The Challenges of Proteomic Analysis  
While genomes are by comparison relatively static, proteomes are constantly in 
flux, with protein expression, degradation and post-translational modification (PTM) 
prone to change during development or in response to changes in physiological and 
environmental conditions. Proteomic efforts face fundamentally different and more 
challenging problems than those faced by genome sequencing efforts15, 20. With 
technologies like polymerase chain reaction (PCR) and automated gene sequencing 
already established, the challenge of genome sequencing was primarily one of scale. The 
ability to copy and amplify nucleic acid sequences also meant that limited sample was a 
surmountable problem. Equivalent technologies to amplify protein from limited sample 
are not available. Compounding potential sample limitation problems is the inherent 
instability of protein compared to DNA. Even in the absence of proteases proteins may 
undergo degradation, including but not limited to oxidation, making the preparation, 
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storage and preservation of samples critically important to sample fidelity. The large 
dynamic range of protein expression within cells, which can be greater than 106-fold, 
also poses significant challenges to protein analysis. It is difficult enough to attempt to 
analyze proteins present only in a few copies in a cell (such as transcription factors), 
much less to attempt their detection within a complex milieu of other proteins, many of 
which are expressed at orders of magnitude higher abundance (such as ribosomes). 
Proteins may also be modified post-translationally. Post-translational modification of 
proteins may be static, or as with their expression, may be variable, adding complexity to 
the proteome far beyond that encoded by the genome. 
1.4 Protein Post-translational Modification  
 Post-translational modification (PTM) of proteins is a process wherein 
polypeptides are enzymatically or chemically modified during or after translation. It 
represents a mechanism whereby cells can achieve a far greater diversity in protein 
expression and function than allowed for by the genetic code. PTMs, which include 
covalent modifications and protein cleavage, alter the structural and biochemical 
properties of proteins and play diverse roles in cellular physiology21. Hundreds of PTMs 
have been identified, with tens of thousands of proteins being targeted22 (http:// 
dbptm.mbc.nctu.edu.tw/statistics.php). In bacteria, where alternative splicing of genes 
does not occur, protein PTM represents a major contributor to protein isoform 
heterogeneity and proteome complexity. In addition to providing a mechanism whereby 
cells may rapidly respond to physiological changes in cellular environment, PTMs may 
allow cells to forego the time-consuming and resource-expensive dependence of altering 
gene transcription and protein translation profiles. Amongst the more common bacterial 
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protein PTMs are N-terminal methionine cleavage, methylation, acetylation and 
phosphorylation23-29. Aside from its role in protein maturation, bacteria employ PTMs in 
the regulation of critical cellular processes such as signal transduction30-32, 
chemotaxis33-36 and protein translation29, 37, 38. The ability to identify expressed proteins 
and characterize both the presence and locations of any PTMs is essential to 
understanding bacterial protein heterogeneity and by extension the numerous 
physiological changes for which they are responsible. 
1.4.1 Ribosomal Protein Post-translational Modification 
 The bacterial ribosome consists of protein and ribonucleic acid (RNA) in a 
bipartite structure, forming a macromolecular machine at the heart of the cellular 
biogenesis39. Ribosomes are responsible for all polypeptide synthesis in the cell, 
translating the messages encoded in bacterial genomes to protein by decoding the 
intermediary messenger RNA (mRNA). Both ribosomal structure and function is highly 
conserved in prokaryotes. It has been the focus of intense structural, biochemical and 
functional research for decades yet still there remains much we do not understand about 
its function40-49. Many PTMs have been discovered on ribosomal proteins but their 
functions remains largely a mystery37, 38, 50. The high level of conservation of the 
metabolically expensive process of ribosomal protein modification however suggests that 
their true significance to the cell remains to be uncovered51. 
 One likely reason for this apparent incongruity is simply that the conditions under 
which the modifications are most apparent still remain to be uncovered. Indeed in the 
cases where phenotypes have been associated with of the loss of ribosomal protein 
modification they have been found to be growth condition associated52-55. Another 
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possible reason is that these studies have primarily focused on roles for the modifications 
on ribosomal assembly and translation rates. 
 There are two intriguing avenues through which ribosomal protein modification 
may yet prove to exert a strong influence that remain to be examined closely. One such 
avenue lies in the extraribosomal functions of ribosomal proteins i.e. functions of 
individual proteins beyond their roles as part of the holoribosome. Speculation and 
interest in extraribosomal functions of ribosomal proteins have been growing in the face 
of mounting evidence that ribosomal proteins exert influence far beyond the realm of 
translation56-58. While the majority of such examples are currently from eukaryotes, 
several ribosomal proteins have been shown to play key roles in the 
complex regulation of ribosome biogenesis in bacteria42. In the majority of elucidated 
cases this regulation is achieved through interaction of a protein with its own, often 
polycistronic, mRNA. Whether individual proteins’ roles in transcriptional regulation is 
relegated to translation-related transcripts or extends to other mRNA species is an area of 
ongoing research interest. 
 A second area where ribosomal protein PTM may play a significant role in 
cellular physiology is in modulating which mRNA transcripts are translated by the 
ribosome under different conditions. Mauro and Edelman have proposed that the 
ribosome itself acts as a regulator of translation by directly and specifically interacting 
with cellular mRNA via both rRNA and ribosomal proteins, in a mRNA sequence- 
specific manner59, 60. In the aptly-termed ribosome filter hypothesis it is the ribosome as a 
whole, inclusive of rRNA, that regulates or ‘filters’ which mRNA are preferentially 
translated under different conditions. Thus far the majority of examples cited in support 
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of the filter hypothesis have been in eukaryotes. The prevailing view is that the ribosome- 
mRNA interactions are modulated through heterogeneity within the ribosomes in cells. 
 To ascertain the potential for heterogeneity within bacterial ribosomal protein as a 
mechanism via which the ribosome could influence translation, we sought to characterize 
the heterogeneity present within the ribosomal proteins of the Gram-negative model 
bacterium, Escherichia coli. 
 The E. coli ribosome consists of 3 ribosomal RNA (rRNA) molecules and 53 
proteins divided into a large (50S) and a small (30S) subunit. A characterization of 
ribosomal heterogeneity faces many of the same challenges discussed in section 1.2.1. 
Ribosomal proteins are high in abundance, accounting for over 40% of the dry cell mass 
in E. coli. However potential secondary isoforms of individual ribosomal proteins may be 
many orders of magnitude less than that of the primary isoform. Identifying any low-
abundant isoforms would be additionally stymied by other highly-abundant ribosomal 
protein species. These factors combine to make the sensitivity of protein detection critical 
to the success of any heterogeneity analysis. 
 The prevalance of post-translational modification on ribosomal proteins adds to 
the challenge of protein identification and characterization, not only because it increases 
the complexity of the protein mixture in question, but also because PTMs result in a final 
product whose physical and chemical properties cannot be accurately predicted from the 
known gene sequences. As such, any successful characterization of E. coli ribosomal 
protein heterogeneity would also require the ability to identify protein isoforms due to 
any combination of PTMs. 
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1.5 Mass Spectrometry 
 The multiple challenges presented by the propsed analysis of ribosomal protein 
heterogeneity necessitated the use of analytical techniques that offered high sensitivity, 
accuracy and resolution in order to identify and distinguish between various 
combinations of PTMs and the resulting protein isoforms. Mass spectrometry (MS) 
provided just such a technique. 
 Mass spectrometry is currently one of the most powerful and widely employed 
analytical methods for the high-throughput analysis of proteins and other biomolecules61-
63. It involves determination of the precise mass of ionized, gaseous phase analytes. It 
facilitates rapid analysis of large, complex samples with sufficient sensitivity to detect 
low-abundance proteins. Critically, MS accomplishes all this at a high enough resolution 
to distinguish between analytes that may differ only by a modification to, or substitution 
of, a single amino acid in the polypeptide chain. In the proteomics arena, mass 
spectrometry is most frequently employed in the analysis of proteins and peptides. The 
information generated from mass spectrometric analyses can be employed not only to 
identify proteins present in a sample, but also measure their relative abundances, identify 
post-translational modifications and protein isoforms, probe their structure, as well as 
investigate intra- and inter-molecular interactions. 
1.5.1 Top-down and Bottom-up Mass Spectrometry Analysis 
 MS-based protein analyses can be divided into two general approaches – top-down 
and bottom-up mass spectrometry. The term top-down mass spectrometry is used to refer 
to methods wherein intact proteins are introduced to the mass spectrometer for analysis, 
sometimes coupled with fragmentation of the protein within the instrument to 
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obtain sequence information64, 65. Bottom-up mass spectrometry refers to the analysis of 
peptides rather than intact proteins and includes MudPIT analysis66. In bottom-up 
analyses protein mixtures are typically digested with a protease, such as trypsin, and the 
resulting peptides subjected to MS analysis. Compared to proteins, peptides are less 
troublesome to ionize and analyze by MS. This is partly due to the much smaller mass 
and chemical space they occupy. Bottom-up analysis also offers multiple opportunities 
for identifying proteins in a sample as multiple peptides are produced from the digestion 
of each protein. 
 While both methods are extremely powerful and useful towards protein analysis, 
each has inherent benefits and limitations as it pertains to the tasks of protein 
identification and characterization. Top-down MS allows for analysis of proteins in a 
form closest to their native cellular state. To assign protein identities from top-down mass 
measurements the experimental masses are compared to databases populated with protein 
molecular weight values derived from previous experimental measurements or predicted 
by an in silico translation of gene sequences (figure 1.2). While efficient front-end 
separation coupled with accurate, high-resolution mass measurements may be sufficient 
to allow for protein identification in some cases, distinguishing between isobaric proteins 
(i.e. proteins with the same molecular weight), and full characterization are not possible 
by this method alone. 
 Further confounding top-down MS-based protein identification are the numerous 
biological processes that result in changes to a protein's mass from that which is encoded 
by its gene sequence. Genetic mutations can result in amino acid substitutions or the 
production of truncated protein products. Protein post-translational modification (PTM) 
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may also result in differences between a mature protein's mass and that which is 
predicted from its gene sequence. Bottom-up MS has the advantage of being able to 
distinguish between isobaric proteins as identification is not based on a single mass 
measurement but on the sum of measurements of constitutive peptides. 
 While two proteins may have similar or identical masses, differences in their amino 
acid sequence usually result in a unique pattern of peptides when digested with cleavage 
site-specific proteases. The resulting peptide masses or ‘peptide mass fingerprint; (PMF) 
facilitate identification of the originating protein67-74. In PMF, a list of experimentally 
measured peptide masses is compared to a theoretical mass list generated through an in 
silico digestion of either a database of known protein sequences or alternatively, a 
database of proteins generated through an in silico translation of the entire genome75 
(figure 1.3.) Statistical analysis of the resulting peptide mass matches enables 
determination of the most likely protein(s) from which the peptides originated. 
 While PMF is a fairly standard technique for protein identification, analyses based 
solely on bottom-up methods have inherent limitations for protein characterization as 
well. The primary obstacle to protein characterization using bottom-up data is that such 
methods rarely achieve 100% amino acid sequence coverage of the protein. The result is 
that post-translational modifications may go potentially unobserved with no indication, 
leaving them in the category of “unknown unknowns.” Another critical limitation is that 
all context as to the combinations in which any observed PTMs may occur is lost. While 
the observation of modified peptides may indicate that PTM of the protein occurs, some 
modifications may occur concurrently while others may be mutually exclusive. This leads 
to significant challenges in distinguishing between variable protein isoforms. The sum of 
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the limitations is a reduced ability to discern important physical and biochemical 
characteristics on the biologically active, intact protein.  
1.5.2 Tandem Mass Spectrometry 
 Whether proteins or peptides are introduced to the mass spectrometer, further 
structural data on the sequence of amino acids that constitute the peptide/proteins can be 
gained from fragmentation of the molecules within the mass spectrometer in tandem 
mass spectrometry (MS/MS)76, 77. Tandem mass spectrometry (MS/MS) applies 
fragmentation combined with a second stage of mass spectrometry to obtain sequence 
and structure data directly from introduced proteins or peptides. 
 Tandem mass spectrometry (MS/MS) is most widely applied in bottom-up 
proteomics analyses where peptides are fragmented within the mass spectrometer and 
mass of the resulting fragments measured. The breaking of intramolecular peptide bonds 
may be achieved through any number of processes that most commonly include collision- 
induced dissociation (CID), infared multiphoton dissociation (IRMPD), electron capture 
dissociation (ECD) and electron transfer dissociation (ETD)78-81. Each method produces a 
characteristic distribution of fragment ions82-86 with fragmentation possible both along 
and outside of the peptide backbone (figure 1.4). Fragmentation of the peptide bonds 
produces b-ions and y-ions resulting in a spectrum-representation of polypeptide amino 
acid sequence (figure 1.5). Ideally MS/MS would allow for near complete sequencing of 
a polypeptide chain facilitating the localization of PTMs to specific amino acid residues. 
In practice however, 100% sequence coverage is seldom achieved. Short amino acid 
sequences, or sequence tags, can however be sufficient for unambiguous identification of 
the parent peptide ion, and often, the originating protein. 
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 Fragmentation can also be applied to obtain structural data from intact 
proteins87-89. However difficulties associated with creating and analyzing gas-phase ions 
of large proteins make such analyses challenging. The instrumentation to fragment 
proteins, as well as the informatic tools to interpret the resulting data, are also still under 
development. As such, the fragmentation of intact proteins has yet to become a 
mainstream analytical method within the proteomics community. 
1.6 Instrumentation 
 While the instrumentation employed in mass spectrometry experiments varies, there 
are several constant parameters that demand consideration. These include mass accuracy, 
which refers to the difference between the measured mass and the calculated mass of the 
analyte, (typically measured as percent error or parts-per-million (ppm)), detection 
sensitivity - a measure of how well an instrument can detect small concentrations of an 
analyte, and instrument resolution which is a measure of how well adjacent masses, 
represented as peaks in a mass spectrum, can be distinguished from each other (typically 
measured as the full width at half maximum (FWHM) of the peaks.) The types of, and the 
configurations in which, the three basic components of a mass spectrometer - the ion 
source, mass analyzer and detector - are employed largely determine the overall 
performance characteristics of a mass spectrometer (figure 1.6). 
The ion source is responsible for the aerosolization, vaporization and ionization of 
analytes. The two ionization methods I employed in my dissertation work were 
electrospray ionization (ESI) and matrix-assisted laser desorption/ionizaion (MALDI)90-
93. Both are examples of gentle or 'soft' ionization techniques, which circumvent the 
propensity for large biomolecules like proteins to fragment when ionized. Electrospray 
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ionization is the primary technique used for the introduction of liquid solubilized protein 
to the mass spectrometer. In ESI solubilized protein is dispersed into highly charged, 
aerosolized droplets by the application of a high electric potential between the liquid in a 
thin metal capillary and a counter electrode. Subsequent to aerosolization, the liquid in 
which the proteins are suspended is evaporated away leaving behind the charged analyte 
in the gaseous phase (figure 1.7). To enhance both ionization and evaporation, proteins 
are often solubilized in a mixture of water and highly volatile organic solvents such as 
acetonitrile (ACN) or methanol (MeOH). The solutions typically also contain a charge/ 
proton source such as formic acid (FA) to enhance ionization and increase the 
concentration of charge on the droplets produced. ESI is particularly useful for producing 
charged macromolecules such as proteins and peptides. In MALDI, analytes are 
sublimated from the solid phase directly to a vapor out of a dry, crystalline matrix using a 
laser. The most common matrices used are composed of one of alpha-cyano-4- 
hydroxycinnamic acid (alpha-cyano), 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic 
acid) or 2,5-dihydroxybenzoic acid (DHB) dissolved in a solvent much like ESI. The 
matrix enhances vaporization and ionization, providing a proton source while protecting 
the analyte from direct exposure to the laser, which would otherwise result in its 
disintegration. While MALDI primarily results in the production of singly charged ions , 
ESI by nature produces more complex spectra consisting of a distribution multiply 
charged ions. As a result, ESI of a single protein species results in spectra which contain 
multiple peaks at different mass-to-charge ratios (m/z) due to the multiple charge states in 
which the ions exist (see figure 1.8). 
 The detector provides the output of a mass spectrometer, measuring the current 
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produced upon detection of ions by one of several methods. The type of mass analyser 
employed has a strong influence on mass accuracy, sensitivity and resolution. Three 
commonly employed mass analyzers in the proteomics arena are - time-of -flight (TOF), 
quadrupole (Q) and Fourier transform ion cyclotron resonance (FT-ICR). I applied each 
of these technologies in my research, leveraging the strengths of each. 
 Time-of-flight instruments employ a constant electric field to accelerate charged 
analytes and measure the time required for the ions to reach the detector after traveling a 
known distance through a vacuum94, 95. The ions are separated during flight due to 
differences in their velocities, a direct result of differences in their mass-to-charge ratios. 
Quadrupole instruments effectively filter the charged analytes in an oscillating 
electromagnetic field, allowing only those with certain mass-to-charge ratios to reach the 
detector. This is typically achieved by varying a combination of radio frequency (RF) and 
current potentials which in turn alter the trajectories of the charged molecules as they 
pass between the quadrupoles96, 97. 
FT-ICR instruments measure the image current produced by the ions cyclotroning 
(spiraling) in a static magnetic field, in which the mass-to-charge ratio of a molecule 
determines the frequency of its cycle in the magnetic field98-100. Detectors located within 
the analyzer measure the electrical signal produced as ions repeatedly cycle nearby, 
producing a periodic signal that can be deconvoluted into a mass/charge measurement by 
performing a Fourier transform. Unlike TOF-based and quadrupole-based mass 
spectrometers, where the protein/peptide ions are ultimately deposited at the detector, ion 
detection in FT-ICR instruments is non-destructive, allowing ions to be 'detected' 
multiple times as they oscillate within the mass analyzer. This is one of the key factors 
 
 
 16 
underlying the high sensitivity, mass accuracy and resolution typical of FT-ICR 
instruments. These characteristics make FT-ICR MS ideal for intact protein analyses 
where the large molecular masses are accompanied by large isotopic distributions. 
Isotopic distribution of protein mass is a result of the naturally occurring abundances of 
different isotopes of the constituent elements. The probability of slightly different intact 
masses due to incorporation of different elemental isotopes (e.g. carbon-12 (12C) versus 
the lower abundance carbon-13 (13C) isotope) increases with molecular size. The 
benefits of FT- ICR are however offset somewhat by the longer time required for data 
acquisition and costly nature and availability of the required instrumentation. 
1.7 Protein Separation Techniques 
The advances in mass spectrometry, particularly ionization and mass analyzer 
technologies, represent a major steps towards overcoming the challenges posed by the 
large dynamic range of protein concentration, as well as the need for high sensitivity, 
accuracy and resolving power. However regardless of the configuration of the 
instrumentation employed, conventional mass spectrometers would quickly be 
overwhelmed if faced with the simultaneous analysis of an entire proteome. The practical 
advantages of mass spectrometry to high-throughput protein analysis are only achievable 
if accompanied by efficient front-end separation of complex protein/peptide samples. 
Separation simplifies the chemical complexity of the analyte introduced to the mass 
analyzer at any particular time. It also facilitates MS analysis by reducing the effects of 
ion suppression, a phenomenon wherein one component in a mixture, be it protein, 
peptide or contaminant, suppresses the ionization of another. The end result of ion 
suppression is a disproportionate underrepresentation of the suppressed species in the 
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resulting mass spectra. This can be a critical problem when dealing with low-abundant 
protein isoforms or when accurate quantitation is necessary. Efficient front-end 
separation also facilitates analysis by simplifying the resulting mass spectra, often already 
complicated by factors such as isotopic spread and overlapping protein charge envelopes. 
This in turn facilitates more accurate charge state deconvolution and mass determination. 
Proteins and peptides can be separated by physical properties such as size or molecular 
weight, or by chemical properties such as isoelectric point (pI) or hydrophobicity. 
Depending on the complexity of samples to be analyzed, either one-dimensional or multi- 
dimensional separation schemes may be necessary. Two of the most powerful and 
common techniques employed for protein and peptide separation prior to MS analysis 
that can achieve orthogonal separations are 2-dimensional polyacrylamide gel 
electrophoresis (2-D PAGE) and high performance liquid chromatography methods 
(HPLC). 
1.7.1 Two-dimensional Polyacrylamide Gel Electrophoresis (2-D PAGE) 
 
Two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) first separates 
proteins based on their isoelectric point (pI) in a process known as isoelectric focusing 
(IEF), then separates based on size101-103. 2-D PAGE offers a significant increase in 
resolving power over 1-D gels, and while the detection of proteins at nanogram levels is 
possible, important limitations remain104. 2-D PAGE is quite labor intensive, not 
systematically reproducible, and not ideally suited for high-throughput analyses. 
Limitations on gel loading capacities and dye sensitivity can also hinder the ability to 
observe low-abundance proteins and isoforms in the gel. Highly hydrophobic proteins, 
such as membrane proteins, as well as highly basic or acidic proteins, such as ribosomal 
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protein L7/12, can also prove challenging to resolve in 2-D PAGE analyses. Perhaps 
most critically, it is difficult to extract intact proteins from the gel matrix removing the 
potential for intact MS analysis. As such proteins separated by 2-D PAGE are typically 
subjected to in-gel protease digestion with the extracted peptides subject to bottom-up 
analysis. Even then, 2-D PAGE is not directly compatible with MS analysis as the 
detergent SDS, necessary for protein separation, can severely suppress peptide ionization 
if not removed. 
1.7.2 Liquid Chromatography 
 High performance liquid chromatography (HPLC) has become the technique of 
choice for the separation of complex protein and peptide mixtures prior to MS analysis105. 
In conventional HPLC, the proteins or peptides are solubilized in a liquid mobile phase 
and passed through columns packed with an immobilized stationary phase with which 
they interact. It is the strength and specificity of these interactions that is primarily 
responsible for the resulting separation. Increased interactions with the stationary phase 
result in increased retardation of movement through the column. Proteins/peptides that 
interact the least elute from the column earlier than those which experience stronger 
interactions. Separation thus occurs in time rather than location, with the time an analyte 
elutes from the column referred to as its retention time. Various physical and chemical 
properties of proteins may be exploited in LC including size (size exclusion 
chromatography, SEC), hydrophobicity (reversed-phase chromatography, RP) or charge 
(ion-exchange chromatography, IEC)106. Orthogonal separation techniques i.e. 
separations based on mutually exclusive analyte properties, may be sequentially 
performed. Significant increases in separating power and resolution may be achieved 
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over gel-based techniques through the coupling of multiple, orthogonal LC separation 
methods107. The high reproducibility of LC-based separations is also an advantage for 
proteomics, allowing putative identification of proteins based on their retention 
characteristics alone. 
Whether single or multi-dimensional in nature, a reversed-phase separation is 
typically the final stage prior to introduction to the mass spectrometer. This is because the 
mobile phase in which the proteins elute consists mainly of water and a volatile organic 
solvent such as ACN or methanol, making it highly suitable for electrospray ionization. 
In addition to this flexibility, a major advantage of LC-based separation to mass 
spectrometry-based proteomics research is that LC separation of proteins and peptides 
can be carried out online with MS analysis; i.e. separation can be coupled directly to the 
ion source of the mass spectrometer. It is also much less labor intensive and as such more 
suited for high-throughput applications. 
1.8 Summary 
Mass spectrometry has quickly become the marquee analytical method for high- 
throughput protein analysis because of its ability to achieve high accuracy, sensitivity and 
resolution. While protein identification using MS is a very common practice, full protein 
characterization still poses a number of technical and computational challenges. The 
analysis of intact proteins by top-down MS methods, and the analysis of peptides using 
bottom-up MS methods are each powerful in their own rights, however significant 
limitations towards protein characterization are clearly apparent when either is considered 
alone. 
 The primary aim of this research was to develop an integrated experimental and 
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data analysis workflow that combined the strengths of each method towards the rapid 
characterization of bacterial protein heterogeneity due to variable PTM. This study 
primarily made use of reversed-phase HPLC for both on-line and off-line protein/peptide 
separations and utilized multiple mass spectrometers, encompassing two methods of 
ionization and three types of mass analyzers, in a comprehensive analysis of the level of 
heterogeneity present in E. coli ribosomal proteins. The methodology and results of this 
global ribo-protein analysis are presented in Chapter 2. A more focused MS-based 
analysis of the variable methylation of ribosomal protein L7/12 is presented in Chapter 3. 
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Figure 1.1 
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Figure 1.1. Schematic of a simple bistable switch. A simple bistable switch wherein 
autoregulatory feedback loops in protein expression drive the system to distinct stable 
phenotypic states, either in response to specific stimuli or spontaneously due to stochastic 
processes. Here gene product E acts directly as an enhancer of its own transcription. The 
concentration of protein E, regulated by the protease I, determines the 'on/off' state of the 
switch, switching on if the concentration of E exceeds the threshold necessary for 
initiation of the positive feedback loop. 
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Figure 1.2 
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Figure 1.2. Protein identification using intact protein mass data. Experimental mass 
measures of intact proteins are compared to databases populated with protein masses 
derived from previous experimental data and/or an in silico translation of gene sequences. 
Masses are considered a match if they fall within a user-defined tolerance (typically a 
function of mass spectrometer accuracy.) Matches and identifications are typically scored 
and ranked based on software-specific scoring and statistical algorithms. (a) Both 
experimentally observed proteins Sma I and Krr R are identified through database 
searches. (b) Post-translational modification (*) of Krr R results in an experimental mass 
+14 Da larger than that encoded by its gene sequence resulting in a missed identification. 
PTMs can similarly result in incorrect database identifications. 
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Figure 1.3 
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Figure 1.3. Protein identification from genome sequence using peptide mass data. 
Experimentally measured peptide masses are compared against a database of theoretical 
peptide masses generated from an in silico translation and digestion of the genome. 
Masses within a user-specified tolerance are considered a match. Matched peptides are 
mapped positionally back to the region of the genome from whence they originated. 
Clusters of matches are used to determine protein hits. Protein identifications may be 
derived directly from gene annotation if available. (Figure adapted from Giddings et al.86) 
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Figure 1.4 
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Figure 1.4. MS/MS fragmentation ions. Post-source fragmentation of peptides during 
MS/MS analysis produces multiple fragment ions that can be used to identify the amino 
acid composition of the parent ion. Breakage of a peptide bond results in the formation of 
b-ions and y-ions containing the N- and C-termini of the fragment respectively. 
Fragmentation along the peptide backbone can also produce a, b, c, x, y and z ions. 
Internal fragments (green box), the result of the simultaneous breakage of two peptide 
bonds, as well as immonium ions (blue box) are also commonly observed in MS/MS 
spectra. (Figure adapted from Khatun et al.108) 
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Figure 1.5 
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Figure 1.5. Peptide MS/MS fragmentation spectrum. Tandem MS (MS/MS) spectrum 
of peptide TVLDSGISEVR illustrating amino acid ladder sequence derived from the b- 
ions (blue) and y-ions (green) produced. The amino acid sequence is derived from the 
mass differences between adjacent b- and y-ion series peaks - illustrated for the y7 - y8 
and y8 - y9 ion peaks. Mass differences of 115.0 Da (y7 - y8) and 113.1 Da (y8 - y9) 
identified the amino acids D and L respectively. Additional peaks due to other 
fragmentation ion types (unlabeled, see figure 1.4) may also be used to determine amino 
acid sequence. The relative intensities of the different ion types present in an MS/MS 
spectrum is dependent on the method of fragmentation employed. 
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Figure 1.6 
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Figure 1.6. Three major components of conventional mass spectrometers. The ion 
source is responsible for aerosolization and ionization of the analytes. The mass analyzer 
is responsible for separating analytes and is ultimately dependent on the mass-to-charge 
ratios of the various analytes present. The detector is responsible for measuring the value 
of a quantifiable quality of the charged analytes thus facilitating determination of an 
analytes abundance. 
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Figure 1.7 
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Figure 1.7 Electrospray ionization. Solubilized protein analytes are dispersed into 
charged, aerosolized droplets by the application of a high electric potential between the 
liquid in a thin metal capillary and a counter electrode. The liquid in which the proteins 
are solublized is rapidly evaporated in a process known as desolvation, leaving behind the 
charged, gas-phase molecule for MS analysis. 
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Figure 1.8 
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Figure 1.8. Characteristic charge state envelope produced by ESI. Unlike matrix- 
assisted laser desorption/ionization (MALDI) which typically produces singly charged 
ions, electrospray ionization (ESI) of proteins results in a distribution of multiply charged 
states which constitute the so-called charge state envelope of the protein (denoted by red 
line). An m/z spectrum for a protein of mass (M) = 25 kDa protein is illustrated wherein 
‘M’ is the mass of the protein,‘H+’ represents the mass of a hydrogen ion (proton) and 
‘n’ is the number of protons (charge) on the ion. 
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Chapter 2 
Integrated Top-down/Bottom-up Characterization of Protein Isoform Heterogeneity 
in Escherichia coli Ribosomal Protein 
 
Abstract 
Due to emerging evidence of a regulatory role for the eukaryotic ribosome, we 
examined the biochemical heterogeneity of Escherichia coli ribosomal proteins to 
ascertain the potential for variable post-translational modification in the modulation of 
prokaryotic ribosomal activity. Our combined top-down and bottom-up mass 
spectrometry analyses of a wild-type E. coli strain, and an antibiotic resistant and fitness-
compensated derivative yielded insight into the range of modifications and isoforms 
permissible under typical laboratory growth conditions. Intact-mass measurements were 
used to predict putative modifications with peptide structural analysis by tandem mass 
spectrometry used to identify proteins and investigate specific modification scenarios. By 
integrating multiple mass spectrometric characterizations of both intact proteins and their 
proteolytic peptides we pinpointed numerous cases of N- terminal truncation, 
methylation, acetylation, one β-methylthiolation and an amino acid substitution. These 
analyses yielded evidence of heterogeneity in the chemical modifications present on a 
number of ribosomal proteins including L7/L12, L16, and L33. Our results indicate that 
there is potential for the ribosome to exist in over 3x104 'states' due to differential protein 
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modification, and provides evidence of possible complexity in the modification systems 
targeting ribosomes, with possible implications in modulating ribosomal assembly, 
translation and extraribosomal ribosomal protein activity. 
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2.1 Introduction  
Phenotypic diversity within bacterial populations is a key contributor to bacteria's 
capacity to adapt to and survive variable and often adverse physiological conditions. 
While genetic diversity has long been thought of as the main contributor to bacterial 
phenotypic diversity, a range of mechanisms such as bistable gene expression1 and 
variable protein post-translational modification (PTM) have indicated that phenotype can 
be switched by mechanisms other than genetic mutation. The output of such simple 
systems can in turn determine much larger aspects of cellular phenotype. From a bacterial 
perspective, it makes sense to employ mechanisms such as PTMs that can quickly switch 
a cell into or out of particular phenotypic states or modulate protein function, often 
without the commitments associated with genetic changes, and especially in response to 
conditions that are apt to change far more frequently than favorable mutations, or 
combinations thereof, arise in the genome. 
Examples of distinct bistable population states include the switch to/from genetic 
competence in B. subtilis and activation of the lactose utilization pathway in E. coli2, 3. It 
is also becoming clear that changes in post-translational modifications (PTMs) on 
proteins can drive rapid changes in cellular state or phenotype. A well elucidated case is 
bacterial chemotaxis, where both protein phosphorylation and protein methylation play 
critical roles in signal transduction and receptor sensitivity to environmental ligands4, 5. In 
this work, we studied the diversity of protein PTMs in bacterial ribosomal proteins, since 
both prior work and our own have uncovered a significant number of PTMs whose 
functions largely remain unclear and whose importance may yet prove to be under-
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appreciated in modulating ribosomal function, or perhaps in extraribosomal protein 
functions. 
 The bacterial ribosome is macromolecular machine at the heart of the cell: it is 
responsible for producing all proteins, and without its proper functioning, a cell quickly 
dies. In E. coli, the ribosome consists of 55 proteins and 3 RNA molecules in a bipartite 
structure which assembles on an mRNA molecule to begin translation of the encoded 
message into a protein. The ribosomes of both prokaryotes and eukaryotes are known to 
be extensively post-translationally modified, with both ribosomal RNA (rRNA) and 
ribosomal proteins being targets of modification enzymes, particularly 
methyltransferases6. But many open questions remain about the ribosome, such as: how 
does it respond to differing protein translation needs as the cellular environment changes, 
and what are the roles of the various chemical modifications present on ribosomal RNAs 
and proteins? Numerous rRNA post-transcriptional modifications have been shown to 
strongly impact the function and fidelity of the ribosome, some having been pinpointed as 
having roles in antibiotic susceptibility7. Less is known about the functions of ribosomal 
protein modification, however experimental evidence and high conservation point to 
important functional roles. A few cases have been well-studied, such as the methylation 
of E. coli ribosomal protein L3, suggested to play a role in ribosomal assembly8 and the 
variable acetylation of the L7/12 N-terminus, which stabilizes its interaction with 
ribosomal protein L10 in a growth-stage dependent manner9. In spite of mounting 
evidence of important cellular functions and growth condition-dependent functions, a 
systematic study of the extent, variability and regulation the modifications has not 
previously been undertaken. 
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 In E. coli and other prokaryotes mRNA synthesis and translation are usually 
synchronous. This synchronous coupling of transcription and translation has lent itself to 
the view of the ribosome as a machine with no regulatory propensity. However, multiple 
lines of evidence have been accumulating which indicate that the ribosome may play a 
direct regulatory role on protein expression in the cell. Ribosomal proteins have also 
gained renewed attention for their extraribosomal functions. Extaribosomal functions 
refer to cellular functions performed by ribosomal proteins beyond those executed as a 
component of the assembled holoribosome10, 11. 
 The "ribosome filter" hypothesis put forward by Mauro and Edelman, proposes that 
ribosomes can regulate translation of specific mRNAs through interactions with rRNA 
and/or ribosomal proteins, resulting in either the enhancement or repression of translation 
initiation12, 13. A number of ribosomal proteins have already been shown to influence the 
translation of their own, as well as other translation component-encoding mRNAs 
through direct interactions14. Whether such influence is confined to the control of 
ribosome biogenesis or is a more general phenomenon in bacteria remains to be 
conclusively determined. While the filter hypothesis has slowly gained traction, a major 
challenge to its further elucidation has been determining the specific mechanisms by 
which the filter might operate. Because PTMs are used in many other aspects of cellular 
life to provide readily reversible control over protein or RNA binding and function, they 
are a highly likely suspect for involvement in/control of any ribosome-as-regulator 
functions in bacteria. By investigating whether, as well as how much, heterogeneity 
exists within ribosomal proteins, we sought to gain insight as to whether there are 
sufficient "levers and dials" that would allow the ribosome to be fine-tuned in the manner 
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required by the ribosome filter hypothesis. We applied a combination of top-down and 
bottom-up proteomic technologies to characterize PTM heterogeneity on the proteins in 
the ribosomes of the E. coli K-12 bacterium. 
 Specifically, we examined protein isoforms present in ribosomal proteins isolated 
from wild type (WT) E. coli K-12 strain MG1655 and two derivative strains, using the 
combination of mass spectrometry approaches summarized in figure 2.1. One strain was 
spontaneous mutant (SmR) exhibiting resistance to the ribosome-targeting antibiotic 
streptomycin, and the second, a further derivative of the resistant strain (SmRC), 
generated by serial passage, which exhibited a phenotype of improved growth compared 
to its parent under stress conditions such as late stationary phase. We produced extensive 
intact-mass and bottom-up peptide data, in repeated biological replicates on multiple 
instruments, that were combined to probe the PTM heterogeneity present. We focused on 
low- peak intensity PTM variants that were repeatably observed over multiple 
experiments. 
 The intact mass was useful to predict and constrain the space of possible 
modifications present. However, by itself, the top-down analysis had several limitations: 
even with highly accurate mass measurements, distinct combinations of possible PTMs 
were sometimes isobaric in mass. For example, considering two common types of 
ribosomal protein PTM: the presence of 3 methylations (42.08 Da) ~ = 1 acetylation 
(42.04 Da). Additionally PTMs could not be localized to particular regions or residues on 
a protein, and some proteins did not behave well enough during separation and mass 
spectrometry to be observed in the mass spectrometers. 
 Because of such limitations, we applied complimentary "bottom-up" or "shotgun" 
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approaches in parallel. Peptides, generated through proteolytic digestion of intact 
proteins, were analyzed by tandem mass spectrometry (MS/MS), producing spectra that 
were used to identify the sequence of the peptides and the location of any PTMs. These 
peptide-based approaches have greater detection sensitivity for complex protein mixtures 
than top-down methods. In a bottom-up approach, all it takes is a few well-behaved 
peptides from a protein to definitively identify its presence in the mix. However, the 
bottom-up methods had their own limitations particularly towards PTM and isoform 
analysis. Since not all peptides could be measured in any single experiment, only limited 
coverage across a protein was achieved, meaning that potential modifications could be 
missed. Also, when there were distinct isoforms present, we would observe particular 
peptides both with and without a given modification. However, knowing this could not 
indicate which combinations of PTMs were viable. For example, if we observed 3 
peptides with distinct methylation sites from a single protein, this did not give any 
indication whether it was biologically viable for any given protein to have all 3 
methylation sites occupied at once, or whether the sites were mutually exclusive with 
only one occupied in any given protein, or some case in between. The intact mass was 
vital to sorting this out, providing the big picture of how many methylations were present 
on any given protein isoform. To maximize peptide coverage of proteins, we also applied 
a directed strategy of first purifying and isolating intact proteins by liquid 
chromatography, then digesting the isolated proteins using trypsin and analyzing the 
resulting peptides by matrix assisted laser desorption ionization, tandem time-of-flight 
mass spectrometry (MALDI-TOF-TOF MS/MS) and by electrospray ionization 
quadrupole time of flight tandem mass spectrometry (ESI-Q-TOF MS/MS). 
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2.2 Materials and Methods  
Materials. Salts, buffers, glacial acetic acid and sucrose were obtained from Fisher 
Scientific. RNase-free DNase 1, formic acid and dithiothreitol (DTT) were obtained from 
Sigma-Aldrich (St Louis, MO). RNase Away (Molecular BioProducts, San Diego, CA), 
was used to treat all glassware and RNase/Protease-free water was used to make all 
buffers to minimize RNase activity during the ribosomal extraction procedure. 
Cell culture and ribosome isolation. Each of the three E. coli derivatives was grown 
aerobically in LB broth at 37oC at ~250 rotations/min prior to harvesting. We purified 
ribosomes based on the previously described method of Strader et al.15 Briefly, bacterial 
cell pellets were resuspended in lysis buffer (100mM NH4Cl/ 50mM MgCH3COO/ 
20mM Tris-HCl pH 7.5/ 1mM DTT/ 0.5mM EDTA; 1:2 w:v). Cells were lysed by 
sonication and treated with RNase-free DNase I (20 min at 4°C) prior to clarification by 
centrifugation. Ribosomes and polysomes were isolated via centrifugation through a 
1.1M sucrose-enriched lysis buffer cushion (1:1 v:v, 100,000 x g, 16 hrs., 4°C). The 
resultant pellet was resuspended in ~1ml ribosome buffer (50mM NH4Cl/ 6mM 
MgCH3COO/ 20mM Tris-HCl pH 7.5/ 1mM DTT/ 0.5mM EDTA) and fractionated 
through a 7-30% sucrose/ribosome buffer gradient (17,000 g, 4 hrs., 4oC). Holoribosome-
containing fractions were identified via maximal abs 280nm measurements, pooled and 
centrifuged to pellet holoribosomes (100,000 x g, 16 hrs., 4°C). The pellet was 
resuspended in 1 ml of ribosome buffer and protein separated from RNA by standard acid 
extraction and centrifugation. The clarified ribosome supernatant was dialyzed using 
3500MW cutoff Slide-A-Lyzer cassettes (Pierce, Rockford, IL) against 8 liters ultrapure 
water for a total of 36 hours at 22°C. The clarified ribosome extract was concentrated by 
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lyophilization. Protein concentration was determined using BCA reagent (Pierce) and 
aliquots stored at -80°C until further analysis. 
On-Line Intact Protein MS Analysis. Intact protein MS was achieved reversed-phase 
liquid-chromatography (RP-LC) coupled to electospray ionization (ESI) on two different 
instruments: a Bruker BIOTOF II ESI-TOF and a 9.4 Tesla LC-FTICR. Capillary HPLC- 
FT-ICR-MS was accomplished with a Dionex UltiMate HPLC interfaced directly to an 
Analytica electrospray source (Analytica of Branford, CT) on an IonSpec (Lake Forest, 
CA) 9.4-Tesla (Cryomagnetics Inc., Oak Ridge, TN) HiRes electrospray Fourier 
transform ion cyclotron resonance mass spectrometer. A C4 reversed-phase column 
(VYDAC 214MS5.325 C4 column 300µm id x 250mm, 300Å with 5µm particles, Grace- 
Vydac, Hesperia, CA) and a 75 min. linear gradient run from 100% solvent A (95% 
water, 5% acetonitrile, 0.1% formic acid, 50 mM hexafluorisopropanol) to 100% solvent 
B (95% acetonitrile, 5% water, 0.1% formic acid, 50 mM hexafluorisopropanol) were 
employed for all separations. Because the mass resolution was at least 50,000 for the 
intact protein measurements, the molecular masses of these proteins could be measured 
with isotopic resolution. As previously described by Strader et al.15, the measured most 
abundant isotopic mass (MAIM) of each molecular ion region was used as an 
approximation of the protein’s isotopically averaged molecular mass for further analysis 
as described below. The isotopically resolved molecular mass region of the suspected 
protein was calculated based on its sequence and compared to the measured data from the 
FTICR-MS experiment to provide a ppm accuracy and putative identification. In a 
complementary analysis, proteins were fractionated by RP-HPLC on a Supelco C5 
column (2.1 x 100mm) using a gradient of 10% to 70% acetonitrile/0.1% formic acid at 
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0.1ml/min over 120 minutes in-line with a Bruker BioTOF II ESI-TOF MS (Bruker 
Daltonics, Billerica, MA). The eluent flow was split between the mass spectrometer for 
intact analysis and a 96-well plate fraction collector for subsequent offline peptide 
analysis. The resulting LC-MS data were analyzed using Data Analysis vs 3.2 (Bruker 
Daltonics). Mass spectra were averaged over distinct time ranges determined from the 
total ion chromatogram (TIC) intensity profile. Typical processing consisted of single 
cycle smoothing (Gaussian, Smoothing width - 2 and 0.15 respectively). Spectral 
deconvolution for intact mass assignments was carried out using the Maximum Entropy 
function (Instrument Resolving Power = 10000, Data point spacing = 0.1 m/z, Resolution 
= normal). Where appropriate, spectra were manually corroborated using the Charge 
State Ruler tool against the smoothed mass spectra which allowed visualization of which 
m/z peaks were considered by the deconvolution function in calculating an intact mass. 
Intact protein analysis on the BioTOF II, capable of 20,000 resolving power, yielded 
typical mass accuracies under 50 for the primary isoform detected for each 
ribosomal protein. 
On-Line Peptide MS/MS Analyses. Ribosomal proteins were digested with sequencing 
grade trypsin (1:20 wt/wt, 37°C, 12 hrs.), desalted with an Omics 100 µl solid phase 
extraction pipette tip (Phenomenex, Torrance, CA) and stored at -80°C until LC-MS/MS 
analysis. One-dimensional (1D) LC-MS/MS experiments were performed with a Famos/ 
Switchos/Ultimate HPLC System (Dionex, Sunnyvale, CA) coupled to an LCQ-DECA 
XP Plus quadrupole ion trap mass spectrometer (Thermo Finnigan, San Jose, CA) 
equipped with a nanospray source. A 160-minute linear gradient from 100% solvent A 
(95% H2O/5% ACN/0.5% formic acid) to 100% solvent B (30% H2O/ 70% ACN/0.5% 
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formic acid) was employed. The LCQ was operated in the data dependent mode with 
dynamic exclusion enabled (repeat count 2), where the four most abundant peaks in every 
MS scan were subjected to MS/MS analysis. Data dependent LC-MS/MS was performed 
over a parent m/z range of 400-2000. The SEQUEST algorithm was used to identify MS/ 
MS spectra with their counterparts predicted from a protein sequence database. For all 
database searches, an E. coli proteome database was used, which contained 4,312 
proteins and 36 common external contaminants. All resultant output files from 
SEQUEST were filtered by DTASelect at the 1-peptide, 2-peptides and 3-peptides level 
with the following parameters: SEQUEST, delCN of at least 0.08 and cross-correlation 
scores (Xcorrs) of at least 1.8 (+1), 2.5 (+2) and 3.5 (+3). The DTASelect analysis was 
performed with searches for β-methythiolation of aspartic acid, single acetylations, and 
mono-, di-, and tri-methylated lysines and arginines. Spectra generated by peptides with 
potentially interesting modifications were each reviewed manually. 
Off-Line Peptide MS/MS Analyses. Individual RP-HPLC fractions collected in 96-well 
plates via a post-column flow-splitting during on-line LC-MS ribosomal protein 
separations were digested with sequencing grade trypsin (1:20 wt/wt, 37°C, 12 hrs.), 
desalted using 10 µl ZipTip pipette tips (Millipore Corporation, Billerica, MA) and 
combined with alpha-cyano-4-hydroxycinnamic acid matrix for MS/MS analysis on a 
MALDI TOF/TOF 4700 proteomics analyzer (Applied Biosystems). The instrument was 
operated in data dependent mode with the10 highest intensity peaks in an MS spectra 
automatically selected for MS/MS analysis. The resulting spectra were analyzed using 
ABI’s Data Explorer software, and signal to noise thresholds of 8 and 5 were enforced for 
creation of the MS and MS/MS mass lists respectively. The MS mass lists were also 
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filtered for trypsin autodigest fragments prior to submission to peptide mass 
fingerprinting (PMF) and characterization software. GFS was queried against a database 
comprised of the encoding gene sequences of both ribosomal and potential contaminant 
proteins, identified in the shotgun analysis as being present in our samples. Gene 
sequences were obtained from NCBI. 
 The sequence tag feature of GFS was used to identify post-translationally 
modified peptides. MS/MS spectra of peptides whose experimental precursor mass 
differed from the sequence prediction, and which had a predicted sequence tag of at least 
three amino acids were further examined manually to confirm the presence of a 
modification and to determine its position. A complementary analysis of these data was 
performed using Mascot (Matrix Science) as part of an automated pipeline to query 
against all proteins from E. coli contained in the MSDB database as of March 2006. 
Proteins with total PMF scores (including ion scores) greater than 95 were reported as 
significant (p<0.05). MS/MS mass lists in the ‘.pkl’ format were submitted to Mascot’s 
MS/MS ion search tool. The masses were queried against all E. coli proteins in the 
MSDB database. Both GFS and Mascot searches considered enzymatic digestion by 
trypsin and allowed a maximum of 2 missed cleavages. The most commonly considered 
variable modifications included acetylation and mono-, di- and tri-methylation of lysine 
and arginine. A peptide tolerance of 100ppm and an MS/MS tolerance of 0.3Da were 
employed for the Mascot searches. 
Intact MS Analysis for isoform and PTM Prediction. To identify proteins and putative 
isoforms/modifications, intact-protein mass measurements were analyzed using both 
PROCLAME and a custom database of all known E. coli proteins along with common 
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modifications. Considered in the database search were commonly-known ribosomal 
modifications including N-terminal loss of methionine, methylation, acetylation, β- 
methythiolation, as well as potential byproducts of protein preparation and ionization 
such as oxidation of methionine or sodium adducts. PROCLAME was run in batch mode 
with a fuzzy cutoff score of 0.6 and a precision of 100ppm, analyzing average isotopic 
mass. In addition to the modifications considered by the database search, it considered 
possible N- or C- terminal truncations of arbitrary length. Previously observed ribosomal 
modifications were assigned higher frequency (FreqScore) and probability (P-score) 
scores, which in PROCLAME has the effect of focusing more of the search space on 
these modifications, while still allowing for novel modifications. 
 The PROCLAME predictions for each observed mass were manually examined in 
conjunction with the bottom-up data (described below) for those scenarios that had 
corroborating peptides and/or were logically compatible with prior PTM observations. 
Criteria for filtering included a high PROCLAME P-score, low error between the 
observed and calculated masses, and logical agreement with previously observed 
ribosomal modifications. Ribosomal protein sequences were obtained from the EcoCyc 
database (http://www.ecocyc.org). Spectra for which distinct masses representing 
putative alternative protein isoforms were identified were subjected to a second manual 
analysis to address any potential for false assignments by the deconvolution algorithm 
due to overlapping protein envelopes or peaks deemed to be due to contaminants. We 
searched both the deconvoluted and smoothed m/z spectra for closely spaced series of 
well-defined peaks that might represent isoform series, moving outwards in both 
increasing and decreasing mass from the most abundant peak. We focused on peaks at the 
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mass expected for the more common ribosomal PTMs (methylation, acetylation and N-
terminal cleavage or lack thereof). We subsequently analyzed the bottom-up data for the 
presence of the predicted modification in detected peptides. In addition to repeated 
observations in the top-down data, we required that each isoform be present in at least 
three distinct charge states in the m/z spectrum. 
Strain generation. The wild type, plasmid-free, streptomycin-sensitive strain of 
Escherichia coli MG1655 (a gift from Dr. Robert Bourret, Dept. of Microbiology and 
Immunology, UNC) was cultured on Luria-Bertani (LB) agar supplemented with 
streptomycin sulfate (50µg/ml, ~ 4 x MIC). A spontaneous mutant colony with resistance 
to streptomycin (SmR) was isolated and serially passaged in LB broth at 37oC on a 12 hr. 
cycle for five days (equaling approximately 256 generations) to select for highest fitness. 
One cfu used to generate a final stock population for the SmRC derivative. The original 
SmR derivative and the final passaged SmRC derivative were directly competed against 
the wild-type predecessor in minimal media into late stationary phase. At 24 and 48 
hours, cell density of each competitor was determined by direct colony counting of 
diluted mixtures on LB agar plates. Differences in growth rates were assessed within a 
95% confidence interval using five independent measures of competition in each case. 
Gene Sequencing. Standard whole-cell PCR from single colonies was performed for 
rpsL gene sequencing to detect polymorphisms that would lead to amino acid 
substitutions located in the proteomic analyses. Primers were designed using the Primer3 
software with default parameters (forward: CGTGTTTACGAAGCAAAAGC, reverse: 
GGCCTTACTTAACGGAGAACC). The thermocycler program consisted of an initial 
lysing/denaturing step (95oC/5mins.), 30 cycles of denaturing (95oC/45sec.), annealing 
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(55-60oC gradient/5mins.) and extension (72oC/45sec.); followed by a final 5min 
extension step (72oC). PCR product size was assessed against a 100bp DNA ladder on a 
2% agarose gel (1xTBE buffer at 75V) stained with ethidium bromide (0.5ug/ml, 30 
mins.) and visualized on a Eagle Eye II system (Stratagene, La Jolla, CA). PCR products 
were purified from the gels using the Qiagen QIAquick PCR Purification kit (Qiagen, 
Valencia, CA) and submitted for sequencing to the UNC DNA Sequencing Facility. 
Contig assembly and sequence analysis was carried out using Sequencher (Gene Codes 
Corporation, Ann Arbor, MI). 
Analysis of contaminant proteins. We used the bottom-up data to determine what 
contaminant proteins co-purified with the ribosomes. This was important to determine 
whether each assignment between a measured intact protein mass and a ribosomal protein 
entry from the database could be a false assignment due to a contaminant with nearly the 
same mass. We observed several proteins in the preparations from all three strains: 
bacterioferritin with 39-63% sequence coverage and 6-8 unique peptides (18,483.3 Da 
predicted mass according to GenBank sequence), GroEL with 23-42% sequence coverage 
and 9-16 unique peptides (55,123.8 Da predicted), and a Co-A linked acetaldehyde 
dehydrogenase with 35-39% sequence coverage and 25-27 unique peptides (96,066.7 Da 
predicted). In the peptide mass fingerprint data, we additionally identified a weak match 
to a putative glycosyltransferase (42,165.2 Da predicted, Q9S519_ECOLI). 
Bacterioferritin is the only one of these contaminants with a mass close to a ribosomal 
protein, L6, but the difference of ~420 Da was enough to distinguish the intact mass 
matches to L6 versus this contaminant.  
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 To estimate the false-positive rate of our top-down database identifications two 
distracter database searches were performed by searching the experimental E. coli mass 
data against Rhodopseudomonas palustris and yeast Saccharomyces cerevisiae ribosomal 
databases. When using the R. palustris ribosomal database, five E. coli ribosomal 
measured masses were identified within 1.0 Da from the R. palustris database; these 
included L31, S17, S10, L36, and L28. Although, L31 was identified with an N-terminal 
methionine truncation for E. coli, that was not matched in R. palustris for this protein. 
For the searches against the yeast database, only three yeast proteins were identified 
within 1 Da using the measured E. coli masses, including the 60S L28, 60S L44, and 40S 
S21 proteins. The yeast 60S L44 protein has homology to the E. coli L12 protein that 
could provide a match within the yeast database. 
Spectra Averaging. For some proteins where peptide MS/MS data was not available to 
support the multiple intact mass observations, we averaged and aligned multiple 
individual charge states from the raw mass spectra. The alignment of multiple charge 
states provided visual illustration of consistency in the spectral data, minimizing concerns 
of artifacts introduced by the deconvolution algorithm. Briefly, m/z ranges (~ ±500 Da ) 
surrounding the predominant mass peak were exported from Data Analysis as mass/ 
intensity pair lists (absolute intensity threshold 5, S/N threshold 2) for three consecutive 
individual charge states in the smoothed raw spectra (e.g. charge states +6, +7, +8) . 
These were used to create an averaged spectrum using the most intense peaks as 
landmarks. SpecAlign vs 2.4 (PTCl, University of Oxford, Oxford, UK) was employed to 
generate the averaged spectra and to carry out an initial alignment using the Recursive 
alignment by fast Fourier Transform function. This averaged spectrum would best 
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represent the data by enhancing S/N ratios, through suppression of noise and 
enhancement of repeated signals across each charge state. To account for small 
differences in inter-peak distances due to PTMs, caused by the differences in charge 
states, we used the Mobility Shift function of our Shape Finder software40 to generate the 
best fit of the three charge states. (N.B. This processing was carried out for data 
presentation purposes only.) 
Combinatorics calculation.  The possible number of states in which the ribosome could 
exist was calculated as the product of the contribution of each ribosomal protein to 
ribosomal heterogeneity. The contribution of a protein to heterogeneity was calculated 
using the combinatorial formula C(n, r) = n!/(r!(n-r)!) where 'n' is the number of predicted 
isoforms of a protein (10 for L7/12, 5 for L11, 2 for L16, 3 for L33 and 5 for S6, 1 for all 
others), and 'r' is the number of occurrences of each protein in the ribosome (4 for L7/12, 
1 for all others). 
2.3 Results 
 A unique feature of this study was the high sampling rate achieved by analyzing 
multiple bacterial derivative samples on multiple mass spectrometers, comprising at least 
a six-fold coverage for the intact analyses. Intact protein MS analyses were carried out on 
a Bruker BioTOF II ESI-TOF MS and IonSpec 9.4-Tesla FTICR MS. Peptide MS and 
MS/MS analyses were undertaken using a Finnigan LCQ quadrupole ion trap mass 
spectrometer and an ABI 4700 MALDI TOF/TOF (MS/MS) (see Methods and 
Materials). Online reversed-phase liquid chromatography coupled to electrospray 
ionization mass spectrometry (RP-LC-ESI-MS) of intact ribosomal proteins combined 
with both online and offline RP-LC-MS analyses of trypsin-digested ribosomal protein 
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allowed identification of all 55 ribosomal proteins in wild-type MG1655, 54 in the 
streptomycin resistant derivative (SmR), and 52 in the compensated derivative (SmRC) 
(see Appendix). Our intact protein analyses yielded the identification of 52 of the 55 
ribosomal proteins with S1, S22 and L34 unobserved by top-down methods. Each of 
these three proteins however were identified in our peptide MS and MS/MS analyses, 
resulting in 100% ribosomal protein identification by bottom-up methods. 
 The vast majority of ribosomal proteins were identified in more than one biological 
sample, with a few exceptions noted later. Protein identifications and PTM predictions 
were made through a combination of - 
1. Comparisons of the experimentally observed intact mass measurements with a custom 
database of all known E. coli proteins, considering a number of common protein 
modifications. 
2. PTM prediction analyses using our PROCLAME software16 accomplished thorough 
comparisons of experimentally observed intact mass measurements with predicted 
masses generated via in silico translation of ribosomal protein-encoding genes, 
considering common ribosomal protein modifications as well as protein oxidation and 
sodium adducts. 
3. Correlation of reversed-phase LC retention times in the top-down LC-MS experiments 
with the peptide mass fingerprint (PMF) identifications from the bottom-up MS and MS/ 
MS analyses generated using our Genome-based peptide Fingerprint Scanning (GFS) 
software17 and Mascot18 (figure 2.2). 
 The data revealed a number of cases where multiple, closely spaced top-down 
masses were found in distinct biological replicate experiments, putatively corresponding 
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to multiple isoforms of ribosomal proteins. In most of these cases, we found that the 
isoform(s) observed in a single experimental analysis of a derivative were present in the 
other experiments as well. One isoform, corresponding to the mass most frequently 
observed in our data and in the literature, was usually of significant abundance, 
sometimes accompanied by one or more less intense peaks representing distinct isoforms. 
This characteristic isoform distribution is illustrated in figure 2.3 for ribosomal protein 
L33. Three isoforms of L33, determined to be due to variable methylation, were 
repeatedly observed across multiple biological samples with the primary monomethylated 
isoform dwarfing peaks due to unmethylated and dimethylated isoforms (figure 2.3). 
 Corroborating peptide evidence (peptide MS and/or MS/MS) was obtained in a 
number of these cases, which allowed confirmation of predictions and localization of the 
PTM(s). Cases where experimental masses were deemed to be solely due to the formation 
of adducts, and/or protein oxidation, were generally omitted from supplementary table 1. 
For reasons discussed later in the paper, one notable exception to this was ribosomal 
protein L16 which, exhibited a primary isoform predicted to be due to possible in vivo 
oxidation. 
 Since the goal of this study was to gauge the level of protein heterogeneity, the 
identification of low-abundance isoforms was critical. This presented the challenge that 
most of the peaks we were interested in had low signal to noise ratios (S/N) in both the 
raw and deconvoluted mass spectra. We applied several selection criteria to aid in the 
differentiation of low-abundance (low S/N) intact masses due real proteins versus those 
due to instrument/chemical noise or software deconvolution artifacts. First, we searched 
for an MS/MS spectrum in the bottom-up peptide data containing a confirmatory 
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modification. Failing that, we studied the MS masses of peptides in the bottom up data to 
find the predicted modifications in those. 
 In the absence of confirmatory peptide MS or MS/MS data supporting an isoform, 
we required observation of an intact mass and its associated PROCLAME PTM 
prediction in more than one biological sample. Mass shifts resulting in distinct isoforms 
that were consistent with previously identified modifications for the same protein, either 
in our work or in published literature, were considered as positive support for a 
prediction. For example, if we had already observed an intact mass showing a single 
methylation with a +14 Da mass shift, observance of a secondary peak in multiple 
biological replicates at ~ +28 Da was considered positive support for a multiply-
methylated isoform. To address possible software deconvolution artifacts, we examined 
raw m/z spectra for the presence of multiple charge states in support of a deconvoluted 
mass. Overlaying multiple charge states (see figure 2.4) often demonstrated strong 
consistency, indicative of an underlying feature rather than noise. 
2.3.1 Proteins Exhibiting Isoform Variability.  
 One contributor to the number of isoforms present was variable N-terminal 
protein processing. We observed 33 of the ribosomal proteins with N-terminal 
methionine truncation, resulting in an intact-protein mass shift of -131.04 Da, in accord 
with previous results19. Of these, 2 additionally exhibited intact masses corresponding to 
isoforms both with and without methionine loss: L11 and L7/L12. Cleavage of N-
terminal methionine is strongly dependent on the length of the side chain of the amino 
acid in position 2, with those having a length less than 2.55 Å (glycine, alanine, proline, 
serine, and threonine) strongly favoring methionine cleavage, and those with a longer 
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side chains like lysine and arginine favoring methionine retention20. Both L7/12 (serine2) 
and L33 (alanine2) follow this rule, with N-terminal methionine loss represented in the 
most abundant isoform. Interestingly S18 also has an alanine in position two, predicting 
that the loss of N- terminal methionine should predominate, as was previously 
observed19. Our lone intact mass observation for S18 however found a predominant peak 
with intact mass of 8,987 Da in the WT strain, indicating the retention of the N-terminal 
methionine. While S18 went unobserved in the other top-down biological replicates, our 
observation indicates there could be a secondary mechanism acting to regulate N-
terminal processing for S18. In general all other ribosomal proteins observed held true to 
this cleavage ‘rule’. We also observed a number of intact protein masses for L7/12 that 
were predicted in PROCLAME to have the second N-terminal amino acid cleaved. These 
predictions were based on top-down mass only and lacked bottom-up support. The E. coli 
methionine aminopeptidase responsible for N-terminal methionine cleavage is highly 
specific and if additional cleavage is indeed occurring it is probably due to a second 
aminopeptidase21. PROCLAME only considers cleavage at one end of the polypeptide 
chain at a time and our analysis was weighted towards N-terminal cleavage as this is 
where the majority of biological cleavage activity occurs. It remains possible that some of 
these masses were due to C-terminally truncated polypeptide products. Ribosomal protein 
S1, discussed later, was not observed in our intact protein analyses however our on-line 
LC-MS/MS analyses identified multiple peptides that indicated variable N-terminal 
processing of S1 also occurs. 
 Our intact mass analyses using PROCLAME indicated that the largest contributor 
to ribosomal protein heterogeneity was variable methylation. We identified 3 proteins 
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(L7/12, L11 and L33) as having possible states due to differences in methylation. The 
primary isoform identified for L33 was ~ 6254 Da, corresponding to the loss of N- 
terminal methionine and a single methylation. We additionally identified an isoform with 
a mass of ~ 6268 Da, assigned in PROCLAME to be the result a second methylation 
event. This mass was consistently observed in the L33-containing fraction for all three 
strains analyzed. L11 has been previously observed undergo N-terminal methionine 
cleavage and three trimethylations at the newly formed N-terminus and two internal 
lysines19, 22. We observed a primary intact mass peak of ~14870 Da, corresponding to a 
loss of N-terminal methionine and the addition of 9 methylations. We observed additional 
mass peaks of that were assigned as corresponding to isoforms containing 2, 3, 7 and 12 
methylations. Each was of significantly lower intensity compared to the primary isoform. 
With the exception of the 12-times methylated isoform prediction, the PROCLAME 
predictions of methylation were accompanied by other modifications such as oxidation. A 
mass of ~ 14911.5 Da observed in the WT and SmRC strains was predicted to be due to a 
loss of N-terminal methionine and the addition of 12 methylations. A precedent for 12 
methylations was established in the L11 homolog in the hyperthermophile Thermus 
thermophilus24. The function of the extensive methylation of L11 remains unclear, with 
the methylating enzyme PrmA having been shown to be nonessential for culture growth 
in both E. coli and T. thermophilus23, 24. 
 The protein L7/12 offered an interesting case, with the number of predicted 
methylations ranging from 0 to 5. PTM assignments were supported by repeated intact 
protein mass measurements as well as the identification of a number of peptides 
exhibiting either ~ +14 Da (mono-methylation) or ~ +28 Da (di-methylation) mass shifts 
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in addition to the unmodified sequence mass. Amongst these were three repeatedly 
observed masses at ~ 1044.6 Da, 1058.6 Da and 1072.6 Da, forming a mass series 
corresponding to sequential methylation (figure 2.4). MS/MS analysis identified that 
variable methylation of the tryptic peptide 75-GATGLGLKEAK-85 was occurring with 
un-, mono- and di-methylated isoforms identified. Lysine 82 was identified as the 
location of methylation in each case (figure 2.5). Our bottom-up analyses identified a 
number of additional peaks at m/z corresponding to mono-methylated tryptic L7/12 
peptides. These had not been selected for fragmentation analysis in the data-dependent 
MS/MS runs due to their low intensities, so further analysis is underway to definitively 
identify the peptides and confirm their modification status. The top-down data 
nonetheless pointed to the presence of methylation sites other than those identified at 
Lys82. 
 Ribosomal protein L16 exhibited two major isoforms with intact masses of 
~15311.5 Da and 15327.4 Da, predicted as being due to methylation plus a single and 
double oxidation respectively (see figure 2.4). The N-terminus of L16 has previously 
been reported to be methylated25. In their analysis of E. coli ribosomes Arnold et al.19 
observed L16 at a mass of 15326.2 Da and partially attributed this mass to an unknown 
modification of Arg81, while discussing the possibility of protein hydroxylation. Our 
MS/MS peptide analyses identified oxidation at Arg81 and Pro69. Sometimes considered 
an experimental artifact in MS analysis, protein oxidation also commonly occurs in vivo, 
typically in response to oxidative stress, altering protein stability and function26. From the 
conservation of the observed intact mass between Arnold's and our work, and its 
localization to a proline residue, it is likely that the ~ +16 and +32 Da mass shifts 
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observed were due to in vivo enzymatic hydroxylation. Proline is the most frequently 
hydroxylated amino acid (from http://dbptm.mbc.nctu.edu.tw). This raises the possibility 
that some isoforms we excluded from this analysis as being due to experimentally- 
induced oxidation could instead be due to in vivo modification of other ribosomal 
proteins. 
 S1, the largest of the ribosomal proteins with predicted sequence mass of ~ 61 kDa, 
has proven difficult to isolate and analyze in both the previous top-down MS studies and 
our own. S1 was efficiently purified with the ribosome complex using our extraction 
methods, indicated by its identification in the bottom-up analyses where we achieved a 
total of over 67% protein sequence coverage. While a lack of intact mass measurement of 
ribosomal protein S1 precluded obtaining a big picture of its protein isoforms, the 
bottom-up analyses indicated that S1 is a source of protein heterogeneity in the E. coli 
ribosome. Two isoforms of the protein N-terminus peptides, one at m/z 1529.4 indicating 
cleavage of the N-terminal methionine (2-TESFAQLFEESLK-14) and one at m/z 1660.8 
(1-MTESFAQLFEESLK-14) indicating its retention, were identified in the on-line 
peptide LC-MS/MS analysis. Both peptides had MS/MS ion coverage above 70%. N-
terminal cleavage statistics indicate the methionine-cleaved isoform should predominate 
as proteins with threonine at amino acid position 2 are cleaved approximately 90% of the 
time27. Our data reflected this with the cleaved (1529.4 m/z) peptide observed 8 times as 
frequently as the uncleaved (1660.8 m/z) peptide. We also found a third peptide at 1571.2 
m/z (78% MS/MS ion coverage) indicating putative acetylation of the cleaved N-
terminus. Taken together, these data indicated the presence of three S1 isoforms due to 
variable N-terminal processing alone. 
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 Ribosomal protein S6 is known to be post-translationally modified by the enzyme 
RimK, responsible for the addition of up to 4 C-terminal glutamic acid residues28. Intact 
S6 was observed once in our top-down analysis of the SmR derivative at a mass of 
~15445.6 Da, corresponding to the addition of two glutamic acid residues. 
 Ribosomal protein S12 presented an instance of protein variation between the 
different strains. Through the combination of top down and bottom up analyses we were 
able to identify a single amino acid substitution K42T in the streptomycin resistant SmR 
and SmRC strains (figure 2.6A/B & table 2.1). The assignment was supported by two 
lines of evidence: a measured intact mass of within -1.9 ppm mass error of the calculated 
value for the substitution and MS/MS analyses of peptides in the bottom-up data 
indicating an amino acid substitution at position 42. Further confirmation came from a 
single nucleotide substitution detected by sequencing the encoding rpsL gene. Single 
amino acid substitutions at Lys 42 in S12 were previously associated with streptomycin 
resistance in a number of bacteria, with some imparting a fitness cost on the bacteria via a 
reduction in translational efficiency manifested as slower growth29, 30. We had observed 
both streptomycin resistance and slow growth phenotypes in the SmR and SmRC strains, 
likely associated with this mutation. 
 We also identified a ß-methylthiolation of aspartate 88 (D88) consistently in all 
three strains, a PTM originally discovered by Kowalak et al.31. Our observation of its 
conservation across the WT and streptomycin resistant strains is in accordance with those 
of Carr et al.32 whose work indicated that the ß-methylthiolation of S12 is not affected by 
the acquisition of streptomycin resistance. 
 We detected only one isoform for each of the remaining ribosomal proteins in the 
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replicate intact analyses for the growth conditions examined. Where observed, the intact 
mass measurements were consistent across all three strains analyzed. For example, in 
ribosomal protein S5 we identified an N-terminal methionine loss and subsequent N- 
terminal acetylation in all three strains, confirmed in both intact MS and bottom up data, 
corroborating prior observations 19. Unlike the variably N-terminal acetylation of L7/12, 
no mass corresponding to an unacetylated S5 was observed, indicating a high efficiency 
of the cognate acetyltransferase, possibly through a tight coupling with translation. 
Similarly in S11, six distinct top-down measurements indicated N-terminal loss of 
methionine plus a single methylation, with the methylated peptide identified in the 
bottom up data for the SmR and SmRC strains. 
 Ribosomal proteins S1, S22 and L34 were the only proteins not identified in our 
intact mass analyses. The small ribosomal proteins S22 (~5 kDa predicted) and L34 (~5.3 
kDa predicted) were identified by bottom-up analyses with ~ 71% and ~ 58% protein 
sequence coverage respectively. All matched peptides for S22 and L34 were void of 
PTMs. 
2.4 Discussion  
 While generally considered to be highly conserved and static, our analysis indicates 
that under just a single growth condition, variability exists in at least three modification 
systems targeting ribosomal proteins – acetylation, methylation and N- terminal 
processing. While some of the isoforms predicted solely from intact mass observations in 
this study require further validation, our TD/BU MS analysis adds to a growing field of 
evidence in support of the ribosome being a complex cellular machine with many 
possible distinct states partially modulated by PTMs on ribosomal proteins.  
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 Several groups have previously studied ribosomal proteins from various 
prokaryotes using either, or a combination of, top-down and bottom-up MS approaches15, 
19, 33. While no single study reported the level of heterogeneity uncovered in this work, 
support for said heterogeneity can be gleaned from some of the results. In an MS analysis 
of purified Rhodopseudomonas palustris ribosomal proteins, Strader et al. 15 observed a 
number of intact mass species that potentially altered forms of ribosomal proteins. In an 
MS analysis of the ribosomes of Caulobacter cresentus, Running et al. 33 observed what 
appeared to be a secondary, less abundant isoform of ribosomal protein L7/12.  
 The integration of top-down and bottom-up MS analyses, combining independent 
biological replicates, multiple E. coli strains, and multiple analysis approaches, 
uncovered a significantly higher level of protein isoform heterogeneity than observed in 
previous studies. When these results are considered in combination with the previously 
reported results, it starts to appear that variable and heterogeneous post translational 
modification of ribosomal proteins is common across prokaryotes. 
 Early biochemical surveys of ribosomal protein methylation by Chang pointed to 
some variability in ribosomal protein L7/12 methylation under different growth 
temperatures34. Additional non-MS studies provided evidence of growth stage-dependent 
and growth condition-dependent ribosome composition and PTM variation, suggesting 
that a wide variety of growth conditions would need to be sampled to obtain a complete 
picture of the full diversity of possible states35, 36. 
 Many of the protein isoforms we observed were due to variable methylation. 
Methylation is a common means of regulating the function of nucleic-acid binding 
proteins37 and frames a potential role for variable PTMs as a mechanistic component of 
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the ribosome filter hypothesis - possibly with different species of ribosomes existing in a 
cell and modulating the translation of different mRNA species. While the N-terminal 
acetylation of L7/12 has been shown to affect its protein-protein interaction with L10, 
direct evidence for a function of ribosomal protein methylation on protein-nucleic acid 
interactions is lacking in bacteria. 
 However, in other classes of organisms, there is evidence that ribosomal protein 
methylation has an effect on mRNA selection for translation. In the slime mold D. 
discoideum, ribosomal protein S24 was found to be required for selective binding of 
certain ribosomal mRNA species, whereas the methylation of S31 resulted in the rapid 
destabilization of ribosomal protein-encoding mRNAs38, 39. The interaction with, and 
modulation of expression of translation-associated mRNAs by individual bacterial 
ribosomal proteins could represent function modulated by variable protein methylation. 
If we include our verified results plus the previously reported isoforms of S6, a 
combinatoric calculation indicates the ribosome may exist in over 3x104 different states. 
This is indeed good evidence that the ribosome has a system of “levers and dials” that can 
be modulated to alter its function or interactions, though the nature of those alterations 
remains opaque. The full extent of the contribution towards ribosomal heterogeneity by 
proteins unobserved in our intact mass analysis may yet be found to be greater than that 
indicated by the limited information afforded by the bottom-up data. 
 While the combinatorial estimate is large, it is likely to be a significant 
underestimate. Several of the modifications are known to be modulated by growth 
conditions, meaning that to find all the heterogeneity we would have to sample all the 
growth conditions, a somewhat arduous task. Also, we noted some weaker and less 
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consistent evidence for other possible isoforms, but did not include them in the results or 
calculations here because they did not meet the inclusion criteria. If even a portion of 
those are later proven to be real variants, it will expand the number of combinatorial 
states considerably. 
It is not clear whether the observed heterogeneity is due to small population 
differences, i.e. each cell exhibits each protein in primarily only a single PTM state, or if 
the full repertoire of heterogeneity exists within individual cells. These two scenarios 
have significantly different biological implications. If the source is population 
heterogeneity, it implies that the variety of isoforms may play a role in adapting to 
environmental stress by readying different cells to respond to different conditions as they 
arise similar to bistability in genetic networks, though in this case the distinct states 
would be represented by different modification patterns rather than distinct modes of 
gene expression. However, if the isoform diversity is at the cellular level, then it may 
have more to do with stochastic fluctuations within the various modification pathways, 
the modulation of which, by intra- or extra-cellular conditions, could provide a 
mechanism for the regulation of mRNA translation via the ribosome. 
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Table 2.1 
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Table 2.1. MS identification of PTM and single amino acid substitution in ribosomal 
protein S12 by GFS. Bottom up peptide MS analysis using GFS identified two distinct 
peptides with delta mass shifts of approximately +46Da and -27Da corresponding to a β- 
methylthiolation and K−>T substitution respectively. Sequence tag analysis of MS/MS 
fragmentation data by GFS pinpointed the D88 and K42 as the location of the respective 
modification and substitution respectively. Matched sequence tags are indicated in red. 
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Figure 2.1 
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Figure 2.1. Protein characterization using a combined Top-down/Bottom-up 
(TD/BU) mass spectrometry approach. LC separated ribosomal proteins were analyzed 
via top- down and bottom-up LC-MS on multiple instruments. Bottom-up MS (shotgun) 
analysis enabled identification of proteins in the sample. Top-down MS (Intact & PMF) 
analysis enabled protein identification and prediction of post-translational modifications 
(and amino acid substitutions) from intact mass measurements. PMF and Tandem MS 
(MS/ MS) applied in both analyses enabled localization of the post-translational 
modifications to specific peptides and/or amino acid positions. 
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Figure 2.2 
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Figure 2.2. Reversed phase liquid chromatography (RP-LC) separation UV trace of 
ribosomal proteins isolated from WT E. coli. Ribosomal proteins were separated by a 
single round of RP-LC with fractions collected at 1 minute intervals in a 96-well plate. 
Following lyophilization and resuspension, individual fractions were enzymatically 
digested with trypsin and analyzed by MALDI MS/MS. For creation of the elution map 
the constituent proteins of each fraction were identified via peptide mass fingerprinting 
(PMF) using GFS and Mascot. 
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Figure 2.3 
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Figure 2.3. Intact isoforms of ribosomal proteins L33 identified in deconvoluted 
spectra. Three isoforms of L33 were observed in ribosomal protein derived from WT 
(black), SmR (red) and SmRC (blue) derivatives. In each case a dominant 
monomethylated isoform at ~ 6254 Da was bounded by two secondary isoforms at ~ 
6240 Da and ~ 6268 Da predicted by PROCLAME to be due to the loss of the N-terminal 
methionine and variable protein methylation (CH2). The intensity axis for each spectra 
were scaled to highlight the very low-intensity 6240 Da and 6268 Da isoforms along with 
the primary 6254 Da isoform peaks. 
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Figure 2.4 
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Figure 2.4. Overlays of multiple charge states in smoothed m/z spectra supports the 
presence of multiple protein isoforms due to differential modification in the m/z 
spectra. For low-abundance isoforms, a key challenge was to determine whether these 
were real, noise or software deconvolution artifacts. Multiple regions of m/z spectra 
representing individual protein charge states (CS) were aligned and overlaid using 
SpecAlign and Shape Finder (see methods). The x-axis indicates the resulting 
deconvoluted intact mass. The averaging of spectra is a good representation of the dataset 
as the suppression of noise and enhancement of repeated signals across each charge state 
are simultaneously achieved. (A) Multiple isoforms of L7/12 were identified due to 
combinations of N- terminal methionine cleavage (-Met), acetylation (Ac) and 
methylation (CH2). (B) Two isoforms of L16 are shown predicted by PROCLAME to be 
due to methylation and either one or two oxidations (Ox). (C) L33 also exhibited variable 
methylation, with masses observed corresponding to methionine loss and either 0, 1 or 2 
methylations. 
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Figure 2.5 
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Figure 2.5. Multiple modification states of a single L7/12 peptide. The peptide 
GATGLGLKEAK corresponding to amino acids 75-85 in ribosomal protein L7/L12 was 
observed by Mascot analysis of MALDI TOF/TOF MS/MS data to be variably modified, 
existing in either (A) an ~ 1058.65 Da monomethylated state or (B) an ~ 1072.66 Da 
dimethylated state. Lys82 was determined to be the site of modification in both peptide 
isoforms. The same peptide was also identified in an unmodified state (data not shown). 
b-ion (green) and y-ion (red) sequences are illustrated. 
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Figure 2.6 
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Figure 2.6. Top-down/Bottom-up MS identified an amino acid substitution in 
protein S12 between strains, a likely determinant of phenotypic differences. (A) 
Total ion chromatogram (TIC) from the LC-FTICR analysis and deconvoluted spectrum 
of the peak at 1.58 mins. (B) Shotgun (MS/MS) analysis of SmR-derived ribosomes 
identified a peptide from protein S12 containing an amino acid substitution (K42T) 
previously associated with streptomycin resistance. (C) DNA sequencing of the SmR 
rpsL locus identified a point mutation in codon 43 in both SmR and SmRC. 
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Chapter 3 
Mass Spectrometry Analysis of Variable Methylation of Escherichia coli Ribosomal 
Protein L7/12 Reveals Novel Methylation Sites and Insights Into Regulation  
 
Abstract 
 
Escherichia coli ribosomal protein L7/L12 is known to be modified by both N-
terminal acetylation and the monomethylation of Lys82. When purified and studied by 
intact-mass spectrometry, additional peaks are often observed in a spectrum, presumably 
due to other modification isoforms. We investigated these additional isoforms through a 
study that combined chromatographic purification and isolation of L7/L12 with analysis 
by both intact-mass spectrometry and bottom-up tandem mass spectrometry. We also 
examined a panel of 28 gene disruption mutants in putative and characterized 
methyltransferases to determine whether any of them disrupt methylation of the protein. 
Finally, we followed a previously noted effect of growth temperature on methylation of 
the protein, by examining specifically how temperature affects each identified site of 
methylation. Our results indicate three new methylation sites, each located in the C-
terminal domain of the protein where it interacts with initiation factor 2 (IF-2), elongation 
factor G (EF-G) and elongation factor Tu (EF-Tu). We observed that growth temperature 
primarily modulated methylation at Lys82 rather than affecting methylation patterns at 
the other sites. It was somewhat surprising that our panel of methyltransferase mutants 
did not identify any effects on L7/L12 methylation, leaving it a remaining mystery. The 
function of the newly uncovered sites of variable methylation in L7/12 remains unclear,
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but the localization of the modified amino acid residues to the C- terminal region 
suggests a role in modulating the interactions of L7/12 with other accessory components 
of the translation machinery. 
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3.1 Introduction  
Though the ribosome is a sophisticated molecular machine that plays a vital role 
in maintaining nearly all cellular life, its complexity has challenged efforts to fully 
elucidate the mechanism by which it is translational behavior is regulated. One aspect of 
the ribosome's complexity is the extensive enzymatic co- or post-translational 
modification that occurs on both its RNA and protein components. Both its RNA and 
protein modifications remain to be fully elucidated, and the role or function of protein 
modifications that have been identified is not clear in most instances.  
Methylation is by far the most common of the prokaryotic ribosomal 
modifications identified. The methylating enzymes - methyltransferases (MTases) - target 
ribosomal RNAs (rRNA), ribosomal proteins, and transfer RNAs (tRNAs). The MTases 
also target various translation factors, indicating a potentially important role in regulating 
or promoting translation. Little is known of the functional significance of the methylation 
of ribosomal proteins, which in Escherichia coli includes ribosomal proteins S11, L3, 
L7/12, L11, L16 and L331. This high frequency of protein methylation comes at a 
significant metabolic cost. It also exhibits a high level of evolutionary conservation 
across bacterial species. These facts suggest that methylation plays important, albeit as 
yet unknown roles in the cell2.  
Most of the methylated proteins have important functions in various aspects of 
translation, and some of them have been the focus of significant research efforts. L3 is a 
monomethylated ribosomal protein that was shown to be important in ribosome 
assembly3. S11, also monomethylated, is located on the platform of the 30S subunit and 
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forms part of the Shine-Delgarno cleft of the 70S ribosome and was shown to be 
important in the control of translational fidelity4. L11, the most extensively methylated 
ribosomal protein, forms part of the GTPase-associated center of the 50S subunit and is 
important in the processes of decoding, tRNA accommodation and translocation5, 6. Few 
ribosomal proteins though have garnered as much interest from the scientific research 
community as L7/12. 
Encoded by the rplL gene in E. coli and differing only in the presence (L7) or 
absence (L12) of an N-terminal acetylation, ribsomal protein L7/12 is the only multi- 
copy protein present in the bacterial ribosome. It is found in the ribosome as a pair of 
heterodimers. It is the main component of the pentameric ribosomal stalk complex and 
associates with the ribosome thorough its interactions with the other stalk component, 
ribosomal protein L10. L7/12 can essentially be divided into three structural regions - an 
N-terminal region (residues 2-38; methionine-1 is typically cleaved) which mediates the 
protein's interactions with L10, a flexible hinge region (residues 39-50) which facilitates 
the numerous conformations that have been observed and links the N-terminal region to 
the C-terminal region (residues 51-121), the latter which plays key roles in translation 
factor recruitment. Extensive studies have enabled elucidation of the structure and 
functional significance of the ribosomal stalk7, 8. 
L7/12 has been shown to directly and specifically interact with initiation factor 2 
(IF2), elongation factors Tu (EF-Tu) and G (EF-G), and release factor 3 (RF3) via a 
conserved region of its C-terminal domain9, and in so doing enhance the GTPase activity 
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of both elongation factors10. Yet despite extensive research, little is known about the 
significance of the PTMs harbored by L7/L12, particularly its methylation. 
 The previously characterized isoforms of L7/12 are due to a combination 
of multiple post-translational modification mechanisms, including N-terminal methionine 
cleavage (methionine-1), N-acetylation of the resulting N-terminal serine-2 (to form L7), 
and internal monomethylation of lysine-82. The enzymes responsible for the N-terminal 
processing of L7/12 have been identified as methionine aminopeptidase MAP11 and 
serine-acetyltransferase RimL, resulting in N-terminal cleavage and acetylation 
respectively12. It undergoes cleavage of Met1 in accordance with the general rule that 
nearly all proteins with small side chains on the residue at position two undergo cleavage 
(approximately 90% cleavage for Ser2)13, 14. 
Though protein N-acetylation is comparatively rare in E. coli, surveys of protein 
N-acetylation in both eukaryotes and prokaryotes suggest that N-acetylation at Ser 
residues has one of the highest likelihoods, explaining the N-terminal cleavage of 
L7/1215. Yet a significant fraction of the cellular L7/12 pool remains unacetylated (L12). 
A number of studies have uncovered evidence of biological regulation of L7/12 
acetylation. Deusser et al16 and Ramagopaul et al17 observed that the ratio of L7 
(acetylated) : L12 (unacetyalted) varied as a function of growth stage. More recently 
Gordiyenko et al showed that this increase served to enhance L7/12's interaction with 
L10, likely as part of a cellular strategy to increase the stability of the stalk under 
stressful conditions18. 
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Early biochemical evidence of L7/12 monomethylation was uncovered by 
Chang20, 21. An increase in the amount of monomethylated L7/12 in cells grown at lower 
temperatures was also noted19. This indicated that there may also be some regulation of 
L7/12 methylation, though much less is understood about it compared to the N-terminal 
processing. These unknowns include both the function significance of the modification 
and the identity of the cognate methyltransferase. 
Arnold and Reilly identified Lys82 as a site of monomethylation in L7/12 by 
mass spectrometry (MS)22. In a recent MS analysis of protein isoform heterogeneity in E. 
coli ribosomal proteins carried out in our lab, we observed a number of low-abundance 
isoforms of L7/12 that hinted at the presence of novel alternate PTM isoforms. Many of 
these exhibited intact masses that were predicted to be due to additional methylations, 
indicating that secondary methylation sites may yet remain to be uncovered. We 
investigated this possibility via tandem mass spectrometry (MS/MS) analysis of L7/12 
peptides wherein tryptic peptides were fragmented in the mass spectrometer to yield 
amino acid sequence information. Those experiments provided the discovery of a new 
dimethylated isoform, dimethylated at the same residue previously known to be harbor a 
single methylation. 
 In the aforementioned experiments, MS/MS was carried out in an automated, 
data-dependent fashion, with only the top 10 most intense peaks in the MS spectra being 
selected for collision-induced dissociation (CID). Hence, some lower-abundance peptides 
were skipped for MS/MS, including some whose precursor masses indicate the potential 
for holding additional methylation sites. This evidence of additional heterogeneity in 
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L7/L12 was too tempting to overlook. We performed further experiments to uncover the 
types and locations of additional modifications present on L7/L12, the nature of 
methylation regulation, and to attempt to identify the enzyme(s) responsible for its 
methylation. 
 To identify any additional sites of methylation we carried out independent 
biological replicate experiments in which we purified L7/12 from E. coli ribosomal 
protein extracts using either reversed-phase liquid chromatography (RP-LC) or one- 
dimensional polyacrylamide gel electrophoresis (1-D PAGE). We then performed both 
electrospray ionization-based (ESI) tandem mass spectrometry (MS/MS) and matrix 
assisted laser desorption/ionization-based (MALDI) MS/MS analyses of L7/12 peptides 
generated via tryptic digestion. We manually targeted peptides for fragmentation analysis 
that were shifted by mass multiples of ~+14 Da, indicative of methylation events.  
We sought insight into the nature and dynamics of the regulation of L7/12 
methylation by conducting additional MS-based analyses of both intact and tryptic L7/12 
protein/peptides derived from cells cultured under two distinct growth temperatures, 
specifically comparing the levels of protein monomethylation under each growth 
condition. To examine whether L7/12 protein may be methylated pre-assembly, we 
constructed and expressed a N-terminally tagged version of the protein in E. coli, adding 
a 6x His-tag at the N-terminus to block L7/12 - L10 interaction, and carried out intact MS 
measurements to determine whether the free protein could be methylated. We 
additionally undertook a MS-based screen of a panel of single-gene knockout mutants of 
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both characterized and putative methyltransferases in an attempt to identify the L7/12 
methyltransferase. 
3.2 Materials and Methods  
Bacterial strains and plasmids. E. coli K12 MG1655 was a kind gift from Dr. R. 
Bourret (UNC Chapel Hill). E. coli strain BW25113 and the single gene knockouts used 
in the screen for the L7/12 methyltransferase were obtained from the Keio Collection - 
National Institute of Genetics, Japan, either directly or via the Coli Genetic Stock Center 
(CGSC) at Yale University. Plasmid pQE-30, used in the expression of the His-tagged 
L7/12, was commercially obtained from Qiagen (Valencia, CA). 
Materials. Salts, buffers, glacial acetic acid and sucrose were obtained from Fisher 
Scientific. RNase-free DNase 1, formic acid and dithiothreitol (DTT) were obtained from 
Sigma-Aldrich (St Louis, MO). RNase Away (Molecular BioProducts, San Diego, CA), 
was used to treat all glassware and RNase/Protease-free water was used to make all 
buffers to minimize RNase activity during ribosome isolation.  
Cell culture. Wild-type E. coli was cultured in LB media and harvested after a 12 hrs. of 
growth. All strains were routinely cultured under aeration at temperatures of either 37°C 
or 28°C as indicated. For E. coli mutants obtained from the CGSC and Keio Collection, 
LB growth media was supplemented with 25ug/ml kanamycin. For the expression of His-
tagged L7/12, cells were first cultured to an OD600 of 0.3 before expression was induced 
by the addition of 10mM isopropyl-beta-D-thiogalactopyranoside (IPTG). Expression 
was carried out for 3 hours before cells were harvested.  
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DNA manipulations. Restriction enzymes were obtained from New England Biolabs 
(Ipswich, MA). Primers and sequencing services were obtained through MWG-Biotech 
(Huntsville, AL).  Digestions, ligations, PCR and cloning were performed using 
manufacturer recommended and standard procedures. Expression of L7-12 was carried 
out in XL1-Blue competent cells transformed with the pQE-30-L7/12 expression vector. 
Briefly a wild type copy of the rplL gene was amplified by standard whole-cell PCR 
 (primers: forward- ATG TCT ATC ACT AAA GAT CAA ATC ATT, reverse- TTA 
TTT AAC TTC AAC TTC AGC GC.) PCR products were purified using QIAquick PCR 
Purification Kit (Qiagen, Valencia, CA) prior to ligation into the pre-linearized pQE-30 
vector using the QIAexpress UA cloning kit (Qiagen) following manufacturer 
recommended protocols. XL1-Blue competent cells were transformed with the His-
tagged L7/12 expression vector using standard heat shock methods. Transformants were 
selected on LB agar plates supplemented with 0.1mg/ml ampicillin.  
Purification of ribosomes. E. coli cultures were harvested by centrifugation, washed, 
and the cells lysed by sonication. Ribosomes were purified as previously described in 
Strader et al. Briefly ribosomes were isolated by pelletting through a 1.1M sucrose/lysis 
buffer cushion and further purified from other large protein complexes by fractionation 
through a 7%-30% sucrose gradient. Ribosome-containing fractions were determined by 
measuring absorbance at 260nm and pooled for protein isolation. RNA was precipitated 
from the ribosome preparation using standard acid extraction techniques and removed by 
centrifugation. The clarified ribosome supernatant was dialyzed using 3500MW cutoff 
slide-a-lyzer cassettes (Pierce, Rockford, IL) against a total of 10 liters of ultra-pure 
18M∧ water (Millipore Corp., Billerica, MA) over 36 hours at 4°C. The ribosomal 
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protein extract was concentrated by lyophilization and the concentration determined by 
measuring absorbance at 280nm using a Nanodrop spectrophotometer (Thermo 
Scientific, Wilmington, DE).  
L7/12 isolation and mass spectrometry analysis. L7/12 protein was isolated from total 
ribosomal protein using either reversed-phase HPLC (RP-LC) or 1-D SDS PAGE. For 
RP-LC approximately 400ug of protein was loaded onto a C5 reversed-phased column 
(Discovery BIO Wide Pore C5, 10cm x 2.1mm, 3µm, Supelco, Bellefonte, PA) and 
separated using a gradient of 10%-70% acetonitrile/0.1% formic acid at a flow rate of 
0.1ml/min. Fractions containing L7/12 were determined from the UV chromatogram and 
confirmed using intact protein mass spectrometry and peptide mass fingerprinting (PMF). 
Isolation of His-tagged L7/12 protein was carried out using the HisLink protein 
purification resin (Promega Corp., Madison, WI). Briefly, clarified supernatant from 
sonicated cell cultures was passed through the resin column to bind the His-tagged 
protein. Protein binding was followed by subsequent wash and elution steps using 
increasing concentrations of imidazloe buffer. Off-line intact mass analysis of RP-LC 
separated L7/12 protein were carried out on either a Bruker BioTOF II ESI-TOF MS 
(Bruker Daltonics, Billerica, MA) or an Applied Biosystems PE Sciex Q-Star Pulsar 
quadrupole time-of-flight (TOF) MS (Applied Biosystems, Foster City, CA). L7/12 
proteins were additionally isolated using 1-D SDS PAGE prior to tryptic digestion and 
MS analysis for modification site determination. Briefly total ribosomal protein were 
separated through 12% precast ReadyGel polyacrylamide gels (Bio-Rad Laboratories, 
Hercules CA) along with reference molecular weight ladder (Bio-Rad Laboratories.) The 
gels were fixed (40% MeOH, 10% HAc) for 30 mins and protein bands visualized by 
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staining with GelCode Blue Stain Reagent (Thermo Scientific, Rockford, IL). Following 
destaining (10% MeOH, 7% HAc) and wash steps, protein bands corresponding to L7/12 
were excised and subjected to in-gel digestion with sequencing grade trypsin (Promega 
Corp.) The resulting peptides were cleaned using 10 µl ZipTip pipette tips (Millipore 
Corp.) and combined with alpha-cyano-4-hydroxycinnamic acid matrix for MS/MS 
analysis on a MALDI TOF/TOF 4700 proteomics analyzer (Applied Biosystems). 
Data analysis. Mass spectra generated on the various mass spectrometers utilized in this 
study were processed using instrument-specific software. Intact protein mass spectra 
obtained on the BioTOF II were analyzed using Bruker Daltonics’ Data Analysis 
software (ver. 3.2.121). Typically spectra were subjected to one round of smoothing 
followed by deconvolution using the maximum entropy function (Instrument Resolving 
Power = 10000, Data point spacing = 0.1 m/z, Resolution = normal). Spectra generated 
using the Q-Star Pulsar were analyzed using Applied Biosystems’ Analyst (ver. 1.1.0) 
software package. Peptide MS and MS/MS spectra generated by MALDI analysis were 
processed and analyzed using Applied Biosystems’ Data Explorer (ver. 4.3) software. 
Intact mass spectra generated on the Q-Star Pulsar were analyzed in Analyst QS (ver. 1.1) 
(Applied Biosystems) with protein intact masses generated using the Bayesian Protein 
Reconstruct function. Peptide mass fingerprinting analysis for protein identification and 
PTM characterization was carried out using Mascot (Matrix Science, Boston, MA) and 
InsPecT (University of California, San Diego), searching against the E. coli K12 MSDB 
and NCBI protein databases respectively. For database searches a maximum of 2 missed 
cleavages, a peptide tolerance of 1 Da and a MS/MS tolerance of 0.5 Da were considered. 
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The most commonly considered variable modifications were acetylation, mono-, di- and 
tri-methylation.  
3.3 Results  
3.3.1 Tandem Mass Spectrometry Identifies Novel Sites of L7/12 Methylation  
 In a previous MS analysis of intact ribosomal proteins we identified masses 
predicted to be the result of multiply methylated ribosomal protein L7/12. To confirm our 
predictions L7/12 was purified from E. coli ribosomal proteins extracts as described in 
the methods and analyzed by tandem MS to characterize any methylated peptides. L7/12 
protein was isolated from ribosomes using 1-D SDS PAGE, excised from the gel and 
subjected to in-gel trypsin digestion. MALDI TOF/TOF MS/MS analyses of the resulting 
tryptic L7/12 peptides were carried out to identify any novel sites of L7/12 methylation. 
Peptide mass fingerprinting (PMF) analysis of the resulting data identified 7 peptides, 
encompassing a minimum of 4 unique modification sites, that exhibited isoforms with 
masses shifted by ~+14 Da, indicative of methylation (figure 3.1). The majority of our 
observations were corroborated in subsequent experimental and independent biological 
repeats. Excluding Lys82, the MS/MS analysis identified three novel sites of protein 
methylation (table 3.1 & figure 3.2). PMF was carried out using Mascot (MS/MS Ion 
Search mode)23 and our Genome Fingerprint Scanning (GFS) software24, searching 
against the MSDB E. coli protein database and the E. coli K12 genome respectively, 
considering variable peptide mono- and di-methylation. 
 The low signal to noise ratios of some peaks in the MS/MS scans, possibly due to 
the low abundance of the peptides themselves, translated into some ambiguity in the 
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assignment of the specific methylated residue in the modified peptides. For example, the 
tryptic peptide GATGLGLKEAK (residues 75-85) (m/z 1058.6) containing the 
previously observed monomethylated Lys82 was identified in Mascot analysis as being 
possibly methylated at either Glu81, Lys82 or Lys85 with similar scores, all above 
Mascot's threshold score for an identity match. Mascot seeks the minimal set of proteins 
that can account for the peptide matches found (the Principal of Parsimony) which could 
potentially result in some bias in the assignment of an MS/MS spectrum to a particular 
protein due to the presence of other peptides matching the same protein. We attempted to 
addressed the possibility that the matching of any low-scoring MS/MS spectrum to L7/12 
may have been biased by the presence of more abundant L7/12 peptides by performing a 
complementary data analysis using InsPecT25. InsPecT, an MS/MS database search tool, 
allows identification of post-translationally modified peptides from a single MS/MS 
spectrum. InsPecT searches were similarly carried out against the entire E. coli protein 
database and largely mirrored the Mascot results, matching each of the modified peptides 
to L7/12 and occasionally indicating alternative methylation sites within a peptide. The 
sites of modification indicated in table 3.1 are the best consensus of both manual and 
software-based spectra analysis. The highest scoring Mascot and InsPecT result from 
software analysis of biological and experimental repeats are indicated where the software 
result agreed with manual analysis. MS/MS fragmentation ion mass lists used in these 
runs are provided as supplementary data. 
 Interestingly, a comparison of the relative intensity ratios of the methylated : 
unmethylated versions of the observed peptides suggest that methylation at the newly 
discovered sites is quite frequent, often indicating a near 1:1 ratio (table 3.1). However 
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intact L7/12 is primarily observed in either unmethylated or monomethylated states 
suggesting that, while not strictly mutually exclusive, monomethylation at one site may 
discourage methylation at another. If this were not the case one would expect multiply-
methylated intact isoforms of L7/12 to be strongly represented in intact MS data. A small 
possibility exists that a fraction of observed protein isoforms attributed to L7 in our intact 
mass assignments could in fact have been due to, and gone undistinguished from, 
trimethylated L12. But if this were the case one would expect to also observe 
trimethylated isoforms of L7. For reasons yet unclear, previous experiments have 
observed that L12 may be monomethylated more readily than L726. Whether the 
mechanisms underlying this disparity could be discouraging higher methylated states of 
L7 remains an interesting area for future analysis. 
 In addition to the discovery of novel monomethylated residues, MS/MS analyses 
of the peptide comprising amino acid residues 76-82 GATGLGLK, and the slightly 
longer 76-85 GATGLGLKEAK, the result of a single missed tryptic cleavage, yielded 
the only case of dimethylation observed in our studies. Both peptides were observed at 
the +14 Da monomethylated mass at m/z 730.41 Da and 1058.61 Da respectively, 
however only the shorter peptide, was observed in its unmethylated state (716.39 Da) 
(figure 3.3). The longer peptide was the only one additionally observed at a mass shifted 
by ~ +28 Da, corresponding to a dimethylation event. Previous MS/MS analysis had 
identified Lys82 as the site of both methylation events. The lack of observation of a 
corroborating dimethylated GATGLGLK peptide at an expected m/z of 744 is likely due 
to a steric hindrance of trypsin cleavage posed by dimethylation at Lys82. The 
dimethylated peptide was on average more than 25 times lower in intensity compared to 
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its monomethylated isoform (based on 4 observations), suggesting that dimethylation is a 
relatively rare event. The dimethylated isoform may simply not be common due to the 
efficiency of the yet unidentified cognate L7/12 methyltransferase. Alternatively 
dimethylation may be dependent on growth conditions or growth stage. EF-Tu, which 
specifically interacts with the C-terminal domain of L7/12, exhibits just such a growth 
phase dependent variation in methylation with Lys56 being monomethylated during 
logarithmic growth and shifting to being primarily dimethylated during stationary 
phase27. 
3.3.2 Temperature-dependent Variation in L7/12 Methylation  
 In light of the earlier work by Chang and our discovery of novel methylation sites 
in L7/12, we sought to determine how L7/12 methylation varied in response to differing 
growth temperatures. A comparative MS analysis of L7/12 protein derived from 
stationary phase E. coli cultures grown at 28°C and 37°C was undertaken to determine 
whether the variable methylation observed in our intact mass measurements was 
influenced by temperature and whether the previously observed increase in methylation is 
due to increased methylation at Lys82 or one of the secondary sites identified in our 
studies. Ribosomal protein from E. coli cultures grown in LB media at 28°C and 35°C 
were isolated and purified as described in the methods. Both L7 and L12 protein isolated 
from cells grown at each temperature were observed as primarily unmethylated and 
monomethylated isoforms. We estimated the relative abundances of unmethylated and 
monomethylated L7 and L12 protein under each growth temperature by calculating the 
area under the peaks, one means of estimating ratios when absolute quantitation is not 
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possible37. This comparison indicated an approximate 5-fold increase in the ratio of 
monomethylated L7/12 protein derived from cells cultured at 28°C, corroborating the 
previous observation (figure 3.4). A similar analysis of Lys82-containing peptides 
derived from proteins at both temperatures indicated a slightly greater than 3-fold 
increase in monomethylation at 28°C (see table 3.2). 
3.3.3 L7/12 Methyltransferase Screen.  
 Unlike the L7/12 N-acetyltransferase, the cognate methyltransferase has not been 
identified. Both our and previous studies suggest that Lys82 is the most prevalent site of 
monomethylation in the protein. Identification of the cognate methyltransferase would 
facilitate studies aimed at elucidation of the functional importance of L7/12 methylation. 
In an attempt to identify potential L7/12 methyltransferase(s) we conducted a rapid MS- 
based screen of intact L7/12 protein isolated from a panel of single-gene knockout E. coli 
mutants lacking either putative or previously confirmed methyltransferases looking 
specifically for significant defects in protein monomethylation. To identify putative 
methyltransferases we used NCBI’s PSI-BLAST algorithm, as well as HHpred28, a 
structure and homology search/prediction tool, to probe the protein databank (PDB) and 
NCBI’s non-redundant protein data bank for E. coli proteins with structural homology to 
two characterized ribosomal protein methyltransferases - PrmA and PrmB. This list 
consisted of uncharacterized and putative methytransferases such as SmtA, YafE and 
YhiQ, as well as a number previously characterized methyltransferases including PrmA 
and PrmB. A list of mutants examined can be found in table 3.3. Cells harboring the 
selected gene deletions were sourced from the Japanese National Institute of Genetics’ 
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Keio Collection, a collection of systematic single-gene E. coli knockouts29. We observed 
neither a complete loss of, nor severe defects in L7/12 protein monomethylation in any of 
the mutants tested. 
 With the identity of the L7/12 methyltransferase unidentified, we sought some 
insight into the timing of L7/12 methylation. To accomplish this we constructed and 
expressed a tagged version of L7/12 using the pQE-30 UA vector system, containing a 6x 
His-tag at the N-terminus. The N-terminus of L7/12 interacts with ribosomal protein L10 
and the tag was chosen in an attempt to disrupt L7/12 incorporation into the ribosome. 
MS analysis of ribosomes derived from cells carrying the expressing the tagged L7/12 
indicated that the tagged version of the protein was precluded from the ribosome. The 
tagged L7/12 was isolated from the cytoplasmic lysate by affinity purification using a Ni-
resin column (Promega HisLink Resin.) Intact MS analysis of the tagged protein 
indicated that ribosome-free L7/12 can be monomethylated. While this observation gives 
little insight into the actual function of the modification, pools of variably methylated 
L7/12 protein could be a possible mechanism through which any extraribosomal 
functions of the protein, such as regulating the translation of its own mRNA, may be 
modulated. 
3.4 Discussion  
 The goal of our study was to confirm predictions that variable protein methylation 
was responsible for multiple protein isoforms of L7/12 observed in a previous MS 
analysis of ribosomal proteins. Our results show that the modification of L7/12 is indeed 
more complex than has previously been thought, with multiple isoforms due to variable 
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methylation being present. Using a combination of intact protein and peptide MS 
analyses we identified at least four distinct sites of methylation, three of which had not 
been previously reported. All of the methylation events we observed were isolated to the 
C-terminal region of the protein. Interestingly the novel methylation sites identified were 
all Glu residues. The methylation of internal Lys, Gln and Arg residues have been 
previously identified in ribosomal proteins of various organisms (reviewed by Polevoda 
and Sherman1). Our analysis offers the first indication of Glu methylation in ribosomal 
proteins to our knowledge. Protein methylation plays a key role in bacterial chemotaxis, 
where the controlled methylation and demethylation of Glu residues of the methyl- 
accepting chemotaxis proteins (MCPs) are known to play a critical role in regulating the 
adaptation to chemotactic stimuli30. Whether methylation of sites within L7/12 is 
permanent or may be similarly removed is unknown, but the methylation of multiple Glu 
residues, a polar, charged residue, in the C-terminal region of L7/12 could have a very 
strong impact on the protein's various interactions, and represents a viable mechanism 
through which L7/12 function could be modulated. 
 The growth temperature-associated changes in the ratio of monomethylated 
protein observed in our work and that of others indicates a need for the cell to regulate 
the modification, which in turn suggests that its functional significance may likely be 
conditional, similar to the N-terminal variable acetylation. Comparing the increases in the 
ratio of intact monomethylated protein (~5-fold) and Lys82-containing peptides (~3.4- 
fold), it is apparent that the increase in protein monomethylation observed at the lower 
growth temperature may not be solely due to an increase in monomethylation of Lys82, 
and that monomethylation at secondary sites may increase as well. The mechanism 
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behind the observed temperature-dependent increase remains unknown. It is possible that 
increased methyltransferase activity is responsible, possibly due to increased expression 
of the enzyme under the low temperature conditions. Alternatively differences in the 
conformation of the highly flexible L7/12 protein at lower temperatures could enhance 
the methyltransferase affinity or accessibility to Lys82 or other sites of methylation. 
Although our results indicate that free L7/12 can be methylated independent of ribosome 
incorporation the exact timing of methylation is not conclusively known. If methylation 
occurs pre-assembly as suggested by our results, slowed ribosomal assembly kinetics at 
lower temperatures could allow more time for the as yet unidentified cognate 
methyltransferase(s) to act on the pool of L7/12 protein thereby reducing the pool of 
unmethylated isoforms available for inclusion into mature ribosomes, thereby explaining 
the increase observed at lower growth temperatures. 
 Intriguingly, some bacteria have been shown to continue to express L7/12 during 
the adaptation to cold shock36. The expression of ribosomal components is highly 
regulated and that cells would continue the metabolically expensive process of producing 
one of the ribosomal proteins while decreasing global translation rates suggests that there 
may be yet undiscovered functions of L7/12 beyond translation. Typically cold-induced 
proteins (CIPs) function as RNA chaperones, binding to mRNA and preventing the 
formation of secondary structures. Whether L7/12 functions in a similar manner remains 
to be investigated, but it would be interesting to analyze whether any significant changes 
to the methylation state of L7/12 occur under cold shock conditions. An increase in 
methylation levels might enhance the protein's ability to interact with mRNA and hence 
function as a chaperone. A decrease in methylation may also be possible if expression of 
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the yet unidentified cognate methyltransferase is diminished or halted all together under 
cold shock conditions. 
 The E. coli genes prmA and prmB have been shown to encode the 
methyltransferases responsible for modifying ribosomal proteins L11 and L3 
respectively. L11, the most extensively methylated ribosomal protein, is tri-methylated at 
three different residues – two internal lysines and an N-terminal alanine. PrmA has been 
shown to be responsible for methylating all three positions and is currently the only 
known lysine methyltransferase in E. coli. PrmB is responsible for the mono-methylation 
of ribosomal protein L3 on a glutamine residue. PrmA and PrmB belong to the class I 
family of S-adenosyl-L-methionine (AdoMet/SAM)-dependent methyltransferases 
(MTases) whose varied substrates include small molecules, nucleic acids and proteins. 
Despite this diverse list of substrates the structure of the catalytic domain of the class I 
family of methyltransferases is highly conserved. The amino acid sequence similarity 
among class I MTases however can be as low as 10%, possibly reflecting the high level 
of diversity in the structure required for the high specificity of methyltransferases across 
such diverse spectrum of substrates. SAM-dependent lysine methyltransferases have 
highly degenerate sequences. We attempted to identify the gene(s) encoding the L7/12 
methyltransferase(s) by screening a panel of E. coli mutants harboring single-gene 
knockouts of putative methyltransferases for defects in L7/12 methylation. The panel of 
mutants examined thus far is not comprehensive, making it possible that we have yet to 
hit the right gene target. Yet our results rule out a number of putative E. coli 
methyltransferases, raising the probability that the cognate L7/12 methyltransferase may 
be an already characterized enzyme performing a dual role in the cell. However, 
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contradicting this theory is that protein methyltransferases are generally highly specific 
for their substrates. 
 Whether L7/12 is targeted by one or multiple methyltransferases remains to be 
determined. Ribosomal protein L11 is methylated at different sites and on different 
residues by a single methyltransferase, setting the precedent that a single protein could 
indeed be responsible for the variable methylation of L7/12 observed in our analyses. In 
such a case, the enzyme, while being specific to L7/12, could have differing affinities or 
physical access to the various methylation sites. The high number of isoforms due to 
variable methylation and large differences in the frequency at which Lys and Glu 
residues  were observed to be methylated however also offer support for a scenario 
involving multiple, residue-specific enzymes. 
 Redundancy in the methylation system, or compensation of the loss of 
methylation at Lys82 by the upregulation of methylation at a secondary site would not be 
distinguished in our intact protein screen. The employment of either system though 
would make L7/12 unique amongst the methylated ribosomal proteins and suggest a 
heightened importance for L7/12 methylation. 
 The functional importance of ribosomal protein methylation in general remains 
somewhat murky with the range of importance ascribed to the methylation of various 
ribosomal proteins being quite disparate. Undoubtedly this is in no small part due to the 
complex cooperativity among proteins and various nucleic acid species (rRNA, mRNA 
and tRNA) involved in translation. This high level of intermolecular crosstalk can make 
drawing conclusions on the importance of a modification from the study of a single 
protein non-trivial - akin to studying just one cog in a complex machine. Indeed the 
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interplay between modifications as well as the conditions under which experiments are 
conducted may yet prove to be critical in teasing apart the roles of ribosomal protein 
PTM. 
 Vanet et al. observed little effect on phenotype upon disrupting E. coli’s three 
trimethylations of ribosomal protein L1131. Such extensive modification of a single 
protein suggests a functional significance to the cell that remains to be uncovered. A 
likely scenario is that we have yet to discover the specific physiological conditions under 
which the function of the modifications are most apparent. Condition-dependent 
phenotypes associated with protein methylation can be found in work carried out by 
Lhoest and Colsen which indicated a role for the lysine methylation of E. coli ribosomal 
protein L3 in ribosomal assembly3. There, a mutant lacking the single L3 methylation 
exhibited a cold–sensitive growth phenotype and aberrant ribosome assembly, a 
phenotype only discernible at lower growth temperatures. A similar temperature- 
dependent phenotype was also apparent when the acetylation of ribosomal protein S5 was 
abolished32. Growth media-dependent phenotypes have also been observed when the 
methylation of release factors 1 (RF1) and 2 (RF2) was abolished33. The prevailing 
evidence suggests that temperature is an important player in L7/12 methylation. Our 
work suggests that the increase in methylation observed in lower growth temperatures is 
mainly due to increased monomethylation at Lys82 and not a shift in methylation patterns 
to a secondary site. With evidence that unincorporated L7/12 can be methylated, the 
increased methylation at the lower temperature could be a result of slower kinetics of 
ribosomal assembly allowing a larger window in which methyltransferase(s) can act on 
the pool of L7/12 protein. 
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 Evidence of L7/12 polymethylation can also be found in other bacteria. In a MS 
analysis of the ribosomes of Caulobacter cresentus, Running et al. observed a likely 
dimethylatyed isoform of L7/12 in addition to the primary monomethylated isoform34. 
They were however unable to determine the site of the additional methylation. Strader et 
al. observed intact masses that suggested the L7/12 homolog in Rhodopseudomonas 
palustris may possibly be trimethylated35. Based on relative abundance measurements in 
our studies and previous MS studies of L7/12 by other labs, Lys82 appears to be the 
primary site of methylation under typical laboratory growth conditions. Whether there are 
growth conditions under which the 'secondary' sites identified herein constitute the 
predominant isoform is unclear. All of the possible methylation sites identified in our 
analysis were located within the C-terminal domain of L7/12 (figure 3.5), which has a 
helix-turn-helix motif comprised of residues 69-87, strikingly similar to those found in 
many DNA-binding regulatory proteins, and may constitute an RNA binding site whose 
interactions could be modulated by the variable methylations. Lys82 is located within a 
region of the C-terminal domain that is highly conserved in bacteria (figure 3.6). 
Helgstrand et al. have shown that EF-Tu, EF-G, IF2 and RF3 all interact with this same 
region of L7/12. How L7/12 methylation affects these interactions remains an interesting 
question for future research. It is highly possible that the methylations modulate L7/12's 
interactions with the G-proteins which in turn could have a significant effect on GTP 
hydrolysis and translation accuracy. 
 
 
 
  118 
Table 3.1 
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Table 3.1. MALDI MS/MS identification of L7/12 methylation sites. Peptides 
identified in MS/MS analyses corresponding to masses due to the unmodified, 
monomethylated (~ +14 Da) and dimethylated (~ +28 Da) sequence. Predicted sequence 
and experimental masses, along with the error (ppm) are listed. Sites of methylation as 
identified via manual and software-based spectra analysis are indicated in bold with '*' 
and '**' indicating monomethylation and dimethylation respectively. Corresponding 
Mascot MS/MS and InSpecT PTM scores are listed. The relative intensity ratios 
represent the ratio of intensities of the modified to the unmodified version of the peptide 
where observed. (ND - not detected; ^ ratio calculated with respect to the 
monomethylated peptide isoform.) 
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Table 3.2 
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Table 3.2. Monomethylated to unmethylated ratios of L7/12 peptides under different 
growth temperatures. MS analysis of observed L7/12 peptides encompassing Lys82 
derived from cells cultured at 28°C and 35°C indicated a more than 3-fold increase (7.2 
 2.1) in the ratio of methylated to unmethylated protein in cells cultured at the lower 
growth temperature.  
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Table 3.3 
Gene  Keio ID  Gene Product Description  
prmA  JW3227-2  Ribosomal protein L11 methyltransferase  
prmB  JW5841-1  Ribosomal protein L3 N(5)-glutamine 
methyltransferase  
smtA  JW0904-5  Predicted S-adenosylmethionine dependent 
methyltransferase  
yafE  JW0200-1  Predicted S-adenosylmethionine dependent 
methyltransferase  
yafS  JW0203-1  Predicted S-adenosylmethionine dependent 
methyltransferase  
cmoA/yecO  JW1859-1  Predicted methyltransferase  
cmoB/yecP  JW1860-1  Predicted S-adenosylmethionine dependent 
methyltransferase  
yccW/rlmI  JW5898-1  23S rRNA methyltransferase monomer  
yfiC  JW2559-1  Predicted S-adenosylmethionine dependent 
methyltransferase  
yfiF  JW2565-1  Predicted methyltransferase  
yhiQ  JW5672-1  Predicted S-adenosylmethionine dependent 
methyltransferase  
tehB  JW1426-2  Tellurite resistance protein  
rsmD/yhhF  JW3430-4  16S rRNA methyltransferase  
rsmF/yebU  JW5301-1  16S rRNA methyltransferase  
rlmL/ycbY  JW0931-1  23S rRNA methyltransferase  
rlmG/ygjO  JW5513-1  23S rRNA methyltransferase  
rlmB/yjfH  JW4138-1  23S rRNA methyltransferase monomer  
ygdE  JW2777-1  Predicted methyltransferase  
ymfD  JW1123-1  Predicted SAM-dependent 
methyltransferase - e14 prophage  
ygdL  JW2783-2  Conserved protein  
mraW/yabC  JW0080-1  S-adenosyl-dependent methyltrnasferase  
yjhP  JW4268-1  Predicted methyltransferase, KpLE2 phage-
like element  
bioC  JW0760-2  Predicted methyltransferase, enzyme of 
biosynthesis  
ybcY  JW0551-1  Predicted SAM-dependent 
methyltransferase  
rumA/rlmD  JW2756-1  23S rRNA methyltransferase  
gatD  JW2075  Galacticol-1-phosphate dehydrogenase  
ybeY  JW0656  Conserved protein - shows similarity to 
metal-dependent hydrolases  
ksgA/rsmA  JW0050  16S rRNA dimethyltransferase  
 
  123 
Table 3.3. Putative and characterized methyltransferases identified in structural 
homology searches to ribosomal protein methyltransferases PrmA and PrmB. Intact 
L7/12 protein isolated from single-gene E. coli knockout mutants were examined by MS 
for loss of methylation in an attempt to identify the cognate methyltransferase. 
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Figure 3.1 
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Figure 3.1 A-D. Raw MALDI-TOF MS spectra of L7/12 peptides. The isotopic 
distribution of unmethylated and monomethylated states of 4 peptides, encompassing a 
minimum of 3 distinct methylation sites, are illustrated in panels A, B, C and D. The 
mass of the monoisotopic peak of both the unmethylated and monomethylated isoforms 
are labelled. Peptide amino acid sequences (residue nos.) were identified through MS/MS 
analysis of the indicated peptide peaks.  
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Figure 3.2 
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Figure 3.2. Novel Glu methylation of ribosomal protein L7/12. InsPecT PTM analysis 
of MALDI TOF/TOF MS/MS spectra derived from the analysis of the L7/12 tryptic 
peptide 53-TEFDVILK-60, observed to be shifted by ~+14 Da in multiple MS spectra, 
identifies Glu-54 (denoted "E*") as a novel site of monomethylation in L7/12.   
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Figure 3.3 
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Figure 3.3. MALDI-TOF MS spectra of peptides containing the variably methylated 
Lys82. A. The tryptic peptide GATGLGLK (76-82) was observed in both a unmethylated 
(m/z 716.39) and monomethylated (m/z 730.41) states but not as being dimethylated. B. 
The peptide GATGLGLKEAK (76-85), the result of a single missed tryptic cleavage, 
was additionally observed to be dimethylated (m/z 1072.6). Previous MS/MS analysis 
identified Lys82 as the site of the dimethylation event. The lack of observation of a 
dimethylated GATGLGLK (76-82) peptide is likely due to inhibition of trypsin cleavage 
at Lys82 when the peptide is dimethylated. 
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Figure 3.4 
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Figure 3.4. Deconvoluted intact mass spectra of L7/12 from cells cultured at 35°C 
and 28°C. Intact protein MS analysis of L7/12 showed an approximate 5-fold increase in 
the ratio of monomethylated protein isoforms of L7/12 at the lower growth temperature 
of 28°C (blue) compared to cells cultured at 35°C (red).   
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Figure 3.5 
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Figure 3.5. Sites of modification mapped onto the structure of the L7/L12 dimer. 
The The DeepView / Swiss-PdbViewer (v 4.01)34 was used to display of the structure for 
the L7/12 dimer (PDB: 1RQU, J Biol Chem 2004). The dimmer is comprised of two 
distinct, organized domains connected by an extensive linker or “hinge” region. The N-
terminal domain is responsible for L7/L12 dimerization and for anchoring the protein to 
the ribosome, through interactions with L10. The C-terminal domain functions as a 
binding site for translation factors. The residues indicated in green were identified as 
being either mono-methylated (K82, Glu51, Glu54, Glu105) or di-methylated (K82), with 
the exception of Ser2 which is acetylated (Ac) in L7 but not in L12. 
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Figure 3.6 
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Figure 3.6. Conservation of bacterial L7/12 protein sequence. The L7/12 protein 
sequence is highly conserved in bacteria. All identified sites of methylation in our study 
were located within the C-terminal domain of L7/12. Lys82, the primary site of 
methylation and the only observed site of di-methylation in our study, is contained within 
a highly conserved stretch of amino acids in the C-terminal domain (green box) that has 
been shown to interact with multiple initiation and elongation factors. 
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Chapter 4 
Conclusions 
  
4.1 Summary 
 Amongst the ultimate goals of proteomics research is the complete understanding 
of cells through the characterization of the complement of proteins expressed, their 
dynamics, interactions and functions. In bacteria, protein post-translational modification 
is a near ubiquitous process. Mass spectrometry (MS) has become one of the most 
important tools within the proteomics community because of its ability to achieve high 
accuracy, sensitivity and resolution protein analysis all in a high-throughput fashion. It is 
a versatile analytical tool that, when utilized to its full potential, can be employed not 
only to identify proteins, but can also aid in their quantitation and structural elucidation, 
identify interaction partners and characterization any post-translational modifications 
(PTMs). Bottom-up MS, the analysis of peptides by MS and MS/MS, allows for 
unambiguous protein identification and can provide structural information on amino acid 
composition as well as the numbers, types and locations of any modifications present. 
While bottom-up MS analysis coupled with peptide mass fingerprinting (PMF) is 
currently the standard forbearer of protein identification in proteomics it has significant 
limitations towards full protein characterization. These stem particularly from the lack of 
information gained on the presence of protein isoforms and the possibility of missed
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PTMs in unobserved peptides. Top-down MS analysis, in which mass measurements are 
directly made of intact proteins, is emerging as the preferred method for protein 
characterization. While high accuracy mass measurements of intact proteins is sometimes 
sufficient to infer identity and discern protein isoforms due to PTMs, the technique is not 
ideal for unambiguous protein identification, or for that matter isoform characterization, 
especially when dealing with complex mixtures. This may be simply due to the potential 
presence of proteins isobaric in mass, or the huge combinatorics of post-translational 
modifications that can result in any observed experimental mass as PTMs can either 
increase or decrease the mass of the mature protein. 
 The work described in this dissertation illustrates that the most critical limitations 
of each method towards protein characterization can be readily addressed when bottom- 
up peptide analyses are combined with complementary MS analyses of the intact proteins 
using available instrumentation and informatics tools. Our research was primarily 
focused on leveraging the strengths of the two main schools of mass spectrometry - top- 
down MS and bottom-up MS - in a synergistic workflow towards the comprehensive 
analysis of protein isoform heterogeneity in Escherichia coli ribosomal proteins. Our 
analysis put us in the company of only a few other research groups that are integrating 
top-down and bottom-up MS towards the characterization of proteins and protein 
complexes. In so doing we have clearly illustrated that currently available MS strategies, 
when combined with an efficient protein separation, can function to identify and 
characterize protein isoforms in complex samples due to PTMs and significantly, indicate 
potentially important genomic mutations through the identification of amino acid 
substitutions. 
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 In a global characterization of ribosomal protein heterogeneity discussed in 
chapter 2, ribosomal protein derived from three E. coli derivatives were analyzed by top- 
down and bottom-up MS methods. Significant impetus for the global analysis of protein 
heterogeneity stemmed from the thought that variable PTM of ribosomal proteins in 
bacteria was a possible mechanism through which the ribosome filter hypothesis might be 
realized. MS studies, using either one or both of top-down and bottom-up MS methods, 
have been previously carried out on bacterial ribosomes1-8. While this study is not the 
first, the comprehensive approach to protein characterization that was undertaken and 
discussed herein enabled the identification of a level of heterogeneity that has previously 
gone unreported. This study was unique for the 6-fold coverage achieved for most 
proteins which facilitated identification of conserved isoforms between the strains and 
previously unidentified PTMs. Our observations show that variable PTM of proteins is an 
avenue through which ribosomal protein function could be modulated. While the specific 
functions of the PTMs identified in our studies and those of others remains unknown, the 
potential impact of the multitude of PTMs and isoforms observed in this study, 
particularly on the function of the finely tuned translation machinery, cannot be 
overlooked. The variable modifications represent a mechanism wherein the ribosome 
filter hypothesis could be realized and could also impact any extra-ribosomal functions of 
the proteins. That such heterogeneity was observed under a single growth condition in 
bacteria with the ability to rapidly adapt to environmental changes suggest that more 
growth conditions need to be examined to get a full picture of the states in which the 
ribosome may exist. 
 This study clearly illustrates the power of such combined approaches to identify 
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not only PTMs, but potentially important genomic mutations. While genome sequencing 
is no longer a time-limiting factor in bacterial characterization, not all mutations result in 
the expression of altered proteins. MS has the advantage over sequencing of 
simultaneously providing information on potentially critical parameters of protein 
expression changes and potential changes to protein interactions and structure without the 
need for the application of additional techniques such as mRNA expression analyses, 
which in and of itself is not always indicative of protein levels. Before such uses of MS 
become widely accepted, advances are necessary that improve the typical protein 
sequence coverage, which in a typical large-scale bottom-up experiment is less than 60%. 
Improvements in separation technologies will also serve to advance the application of 
top-down proteomics. While noteworthy in its characterization of different protein 
isoforms both within and amongst the bacterial strains analyzed, our heterogeneity 
analysis also underlined a major hurdle facing protein characterization using MS. Whilst 
this study was completed using currently available informatics tools, our data analysis 
pipeline illustrated a desperate need for the development of informatics tools that can 
integrate and interpret top-down and bottom-up datasets in an automated 
fashion. Informatics tools for the processing and interpretation of bottom-up MS data 
have largely kept pace with the rapid developments in instrumentation an increasing 
scales and complexity of experiments. However, the development of informatics tools for 
the interpretation of top-down MS data have lagged significantly. Our in-house 
developed PROCLAME software provided all of the PTM predictions carried out in this 
study and were manually checked against the bottom-up MS data. The Protein Inference 
Engine (PIE), developed in the Giddings lab, and PTMSearchPlus9 are the only tools to 
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our knowledge that currently attempt to overcome the daunting challenge of integrating 
bottom-up and top-down MS data. The PIE uses Markov chain Monte Carlo (MCMC) 
methods to integrate top-down and bottom-up mass spectrometry data, drawing on 
multiple sources of biological information (such as residue-specific modification 
frequencies) to predict PTMs and characterize proteins from experimental MS data. 
 One of the more significant challenges that arose during our analyses was that of 
how to correctly distinguish low-abundant protein isoforms, which typically produced 
mass spectra low signal-to-noise ratios (S/N), from peaks due to instrument and chemical 
noise. While hard S/N cutoffs can result in significantly cleaner and by extension, easier 
to interpret spectral data, it was evident from this study that there is significant risk for 
meaningful data to be lost. While we sought to overcome this hurdle by instituting 
multiple data filter criteria, the need for more efficient and less subjective methods 
became quickly evident. Statistical analysis tools that could be applied across multiple 
analyses to calculate likelyhood metrics on whether a given peak is due to random noise 
or genuine signal would be extremely useful as proteomics matures from a field focused 
more on protein identification to one more focused on protein characterization. 
 In chapter 3 we demonstrated that L7/12 is a target for variable protein 
methylation. In a focused analysis of the variable methylation of ribosomal protein L7/12 
that was undertaken subsequent to the identification of L7/12 as one of the more varible 
proteins in our global heterogeneity analysis. We identified a number of novel sites of 
methylation inclusive of a novel dimethylation event. The localization of all of the 
methylations sites we identified to the C-terminus of the protein suggest a possible role 
for methylation in regulation of L7/12's interactions with either one or multiple 
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translation factors, which in turn could have impacts on translation initiation, translation 
fidelity, and ribosome translocation rates. The identifications of these sites directly 
illustrate the aforementioned benefits that better front-end separations and increased MS 
sensitivity would achieve as many of the sites of modification were not characterized in 
the global analysis simply due to the lack of observation of the modified peptides in the 
digests of the complex mixture of ribosomal proteins. Similar focused analyses of other 
ribosomal proteins remain necessary to confirm and identify many modification sites 
predicted in our global top-down/bottom-up analyses. 
 Protein methylation has also been shown to modulate protein-nucleic acid 
interactions raising questions as to whether the purpose of the methylated residues could 
be to regulate mRNA translation - either enhancing expression of certain mRNA species 
by stabilizing them or hindering their expression thorough binding at ribosome entry 
sites. In fact our observation that incorporation into ribosomes is not required for L7/12 
methylation suggests that free pools of variably modified L7/12 are free to perform extra- 
ribosomal functions in the cell. Our experiments probing the regulation of L7/12 
methylation indicated that the levels of methylated protein increased at lower growth 
temperatures. This is possibly due to the slower kinetics of ribosome assembly at lower 
temperatures. While this analysis was focused on L7/12 derived from active ribosomes 
we expect from the aforementioned results that free L7/12 would exhibit a similar 
increase. 
 Improved mass spectrometry and separation techniques are continually being 
developed. It bodes well for the future of high-throughput protein characterization that 
the development of informatics tools to speed the integration and interpretation of top- 
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down and bottom-up datasets is underway in a few labs including ours. As these 
advancements become mainstream the new bottleneck to bacterial characterization may 
indeed become functional elucidation of protein isoforms and modifications identified in 
large scale proteomics experiments. However, as the successes of the genomics 
revolution gave rise to the proteomics era, continued improvements in high-throughput 
protein characterization will no doubt drive innovation in realm of functional proteomics. 
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Appendix A - Summary of Top-down/Bottom-up MS Protein Analyses 
 
Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
          
RpsA S1 61158.18 WT Not Observed         24 853 
61158.18 61158.18 SmR Not Observed         25 781 
  61158.18 SmRC Not Observed         25 770 
                   
RpsB S2 26743.73 WT 26612.51 ESI-FT -MET 26612.53 0.95 9 805 
26743.73  26743.73   26613.26 ESI-TOF -MET 26612.53 -27.24     
  26743.73 SmR 26614.09 ESI-TOF -MET 26612.53 -58.47 14 319 
  26743.73 SmRC Not Observed         11 705 
                    
RpsC S3 25983.30 WT 25852.81 ESI-FT -MET 25852.10 -27.47 13 692 
25983.30 25983.30   25852.41 ESI-TOF -MET 25852.10 -12.18     
  25983.30 SmR 25852.10 ESI-FT -MET 25852.10 -0.31 13 582 
  25983.30   25852.33 ESI-TOF -MET 25852.10 -9.05     
  25983.30 SmRC 25852.03 ESI-FT -MET 25852.10 2.65 10 937 
  25983.30   25855.91 ESI-TOF -MET 25852.10 -147.42     
                    
RpsD S4 23469.15 WT 23337.99 ESI-FT -MET 23337.95 -1.48 9 714 
23469.15 23469.15   23337.80 ESI-TOF -MET 23337.95 6.43     
  23469.15 SmR 23337.95 ESI-FT -MET 23337.95 0.25 12 688 
  23469.15   23338.41 ESI-TOF -MET 23337.95 -19.32     
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Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
  23469.15 SmRC 23337.41 ESI-FT -MET 23337.95 23.27 9 672 
                    
          
RpsE S5 17603.44 WT 17514.22 ESI-FT -MET, Ac 17514.28 3.12 12 389 
17603.44 17603.44   17515.36 ESI-TOF -MET, Ac 17514.28 -61.70     
  17603.44 SmR 17514.31 ESI-FT -MET, Ac 17514.28 -1.62 14 281 
  17603.44   17514.21 ESI-TOF -MET, Ac 17514.28 3.96     
  17603.44   17515.55 ESI-TOF -MET, Ac 17514.28 -72.55     
  17603.44 SmRC 17514.32 ESI-FT -MET, Ac 17514.28 -2.12 10 408 
  17603.44   17516.81 ESI-TOF -MET, Ac 17514.28 -144.68     
                    
RpsF S6 15187.09 WT Not Observed         3 89 
15187.09 15187.09 SmR 15445.63 ESI-TOF C-terminal EE 15445.29 -22.21 4 310 
  15187.09 SmRC Not Observed         3 307 
                    
RpsG S7 20019.14 WT 19889.29 ESI-TOF -MET 19887.95 -67.63 13 465 
20019.14 20019.14 SmR 19888.05 ESI-TOF -MET 19887.95 -5.28 15 503 
  20019.14   19887.97 ESI-FT -MET 19887.95 -1.49     
  20019.14 SmRC 19887.90 ESI-FT -MET 19887.95 2.10 12 492 
                    
RpsH S8 14126.61 WT 13995.44 ESI-FT -MET 13995.41 -2.07 3 237 
14126.61 14126.61   13995.98 ESI-TOF -MET 13995.41 -40.94     
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Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
  14126.61 SmR 13995.31 ESI-FT -MET 13995.41 7.28 2 146 
  14126.61   13995.46 ESI-TOF -MET 13995.41 -3.64     
  14126.61 SmRC 13995.39 ESI-FT -MET 13995.41 1.55 4 156 
  14126.61   13996.72 ESI-TOF -MET 13995.41 -93.53     
                    
RpsI S9 14856.25 WT 14725.03 ESI-TOF -MET 14725.05 1.09 2 237 
14856.25 14856.25 SmR 14725.06 ESI-TOF -MET 14725.05 -0.95 5 196 
  14856.25 SmRC 14724.26 ESI-FT -MET 14725.05 53.63 3 160 
                    
RpsJ S10 11735.62 WT 11735.46 ESI-FT None 11735.62 13.35 6 221 
11735.62 11735.62 SmR 11735.50 ESI-FT None 11735.62 10.37 1 211 
  11735.62 SmRC 11735.62 ESI-FT None 11735.62 -0.51 4 68 
                    
RpsK S11 13844.97 WT 13727.34 ESI-TOF -MET, CH2 13727.80 33.21 3 561 
13844.97 13844.97 SmR 13727.75 ESI-TOF -MET, CH2 13727.80 3.34 6 290 
  13844.97 SmRC 13727.66 ESI-FT -MET, CH2 13727.80 9.90 27 467 
  13844.97   13727.42 ESI-TOF -MET, CH2 13727.80 27.09     
  13844.97   13727.73 ESI-FT -MET, CH2 13727.80 5.11     
                    
RpsL S12 13737.11 WT 13652.15 ESI-FT 
-MET,  
β-methylthiolation 13652.00 -11.19 1 278 
13737.11 13737.11   13649.01 ESI-TOF 
-MET,  
β-methylthiolation 13652.00 219.13     
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Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
  13737.11 SmR 13624.85 ESI-FT 
-MET,  
β-methylthiolation,  
K->T 13624.93 5.92 2 286 
  13737.11   13625.11 ESI-TOF 
-MET,  
β-methylthiolation,  
K->T 13624.93 -13.39     
  13737.11 SmRC 13624.78 ESI-FT 
-MET,  
β-methylthiolation, 
K->T 13624.93 10.89 2 206 
  13737.11   13623.94 ESI-TOF 
-MET,  
β-methylthiolation, 
K->T 13624.93 72.56     
                    
RpsM S13 13099.43 WT Not Observed         10 103 
13099.43 13099.43 SmR 12968.32 ESI-TOF -MET 12968.23 -6.79 10 161 
  13099.43 SmRC Not Observed         9 118 
                    
RpsN S14 11580.52 WT 11448.97 ESI-FT -MET 11449.33 31.09 1 211 
11580.52 11580.52 SmR Not Observed         1 146 
  11580.52 SmRC 11449.16 ESI-FT -MET 11449.33 14.40 1 184 
                    
RpsO S15 10268.79 WT 10137.62 ESI-TOF -MET 10137.59 -2.47 2 61 
10268.79 10268.79 SmR 10137.89 ESI-FT -MET 10137.59 -29.60 1 - 
  10268.79   10137.48 ESI-TOF -MET 10137.59 11.44     
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Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
  10268.79 SmRC 10137.59 ESI-FT -MET 10137.59 0.75 1 177 
  10268.79   10138.26 ESI-TOF -MET 10137.59 -65.60     
                    
RpsP S16 9190.58 WT 9190.60 ESI-FT None 9190.58 -2.93 3 366 
9190.58 9190.58   9190.38 ESI-TOF None 9190.58 21.76     
  9190.58 SmR 9190.20 ESI-FT None 9190.58 40.41 1 394 
  9190.58   9190.67 ESI-TOF None 9190.58 -10.55     
  9190.58 SmRC 9190.20 ESI-FT None 9190.58 40.41 3 142 
  9190.58   9191.89 ESI-TOF None 9190.58 -143.41     
                    
RpsQ S17 9704.48 WT 9573.26 ESI-FT -MET 9573.28 2.04 1 47 
9704.48 9704.48   9573.04 ESI-TOF -MET 9573.28 25.17     
  9704.48 SmR 9573.58 ESI-FT -MET 9573.28 -30.92 1 - 
  9704.48   9572.49 ESI-TOF -MET 9573.28 82.52     
  9704.48 SmRC 9573.12 ESI-FT -MET 9573.28 16.43 1 83 
  9704.48   9572.68 ESI-TOF -MET 9573.28 62.57     
                    
RpsR S18 8986.46 WT 8987.45 ESI-TOF None 8986.46 -110.39 2 - 
8986.46 8986.46 SmR Not Observed         1 - 
  8986.46 SmRC Not Observed         2 56 
                    
RpsS S19 10430.32 WT 10298.43 ESI-FT -MET 10299.12 66.77 3 274 
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Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
10430.32 10430.32   10299.46 ESI-TOF -MET 10299.12 -33.21     
  10430.32 SmR 10299.17 ESI-TOF -MET 10299.12 -5.05 3 263 
  10430.32   10299.02 ESI-FT -MET 10299.12 8.96     
  10430.32 SmRC 10298.69 ESI-FT -MET 10299.12 41.41 2 270 
  10430.32   10299.66 ESI-TOF -MET 10299.12 -52.82     
                    
RpsT 
S20/L26 9684.42 WT 9553.37 ESI-FT -MET 9553.23 -14.99 1 137 
9684.42 9684.42   9553.40 ESI-TOF -MET 9553.23 -17.80     
  9684.42 SmR 9552.87 ESI-FT -MET 9553.23 37.54 4 82 
  9684.42   9553.27 ESI-TOF -MET 9553.23 -4.92     
  9684.42 SmRC 9553.34 ESI-FT -MET 9553.23 -12.14 1 116 
  9684.42   9553.45 ESI-TOF -MET 9553.23 -23.87     
                    
RpsU S21 8499.98 WT 8368.73 ESI-FT -MET 8368.78 6.11 1 391 
8499.98 8499.98 SmR 8368.72 ESI-FT -MET 8368.78 6.90 2 263 
  8499.98   8368.78 ESI-TOF -MET 8368.78 -0.12 2 263 
  8499.98 SmRC 8368.85 ESI-FT -MET 8368.78 -8.37 1 258 
                    
RpsV S22 5095.83 WT Not Observed         0 393 
5095.83 5095.83 SmR Not Observed         0 25 
  5095.83 SmRC Not Observed         0 - 
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Subunit & 
Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
                    
RplA L1 24729.71 WT 24598.41 ESI-FT -MET 24598.51 3.90 16 492 
24729.71 24729.71   24598.80 ESI-TOF -MET 24598.51 -11.83     
  24729.71 SmR 24598.32 ESI-FT -MET 24598.51 7.63 20 458 
  24729.71   24598.74 ESI-TOF -MET 24598.51 -9.39     
  24729.71 SmRC 24598.81 ESI-FT -MET 24598.51 -12.40 16 544 
  24729.71   24603.52 ESI-TOF -MET 24598.51 -203.54     
                    
RplB L2 29860.53 WT 29728.46 ESI-FT -MET 29729.33 29.14 9 496 
29860.53 29860.53   29728.77 ESI-TOF -MET 29729.33 18.84     
  29860.53 SmR 29729.79 ESI-TOF -MET 29729.33 -15.51 12 235 
  29860.53 SmRC 29729.05 ESI-FT -MET 29729.33 9.24 9 214 
  29860.53   29729.57 ESI-TOF -MET 29729.33 -8.24     
                    
RplC L3 22243.56 WT 22257.42 ESI-FT CH2 22257.59 7.66 8 302 
22243.56 22243.56   22258.99 ESI-TOF CH2 22257.59 -62.95     
  22243.56 SmR 22257.60 ESI-FT CH2 22257.59 -0.73 10 282 
  22243.56   22258.30 ESI-TOF CH2 22257.59 -32.13     
  22243.56 SmRC 22257.66 ESI-FT CH2 22257.59 -3.14 8 474 
                    
RplD L4 22086.59 WT 22087.77 ESI-TOF None 22086.59 -53.47 4 528 
22086.59 22086.59 SmR 22086.53 ESI-TOF None 22086.59 2.54 10 590 
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Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
  22086.59   22085.85 ESI-FT None 22086.59 33.19     
  22086.59 SmRC 22087.34 ESI-TOF None 22086.59 -34.32 4 776 
                    
RplE L5 20301.65 WT 20170.54 ESI-FT -MET 20170.45 -4.62 12 426 
20301.65 20301.65   20171.94 ESI-TOF -MET 20170.45 -73.97     
  20301.65 SmR 20170.28 ESI-FT -MET 20170.45 8.09 14 430 
  20301.65   20171.36 ESI-TOF -MET 20170.45 -45.17     
  20301.65 SmRC 20170.46 ESI-FT -MET 20170.45 -0.83 13 403 
                    
RplF L6 18903.82 WT 18773.23 ESI-TOF -MET 18772.62 -32.23 10 452 
18903.82 18903.82 SmR 18772.58 ESI-FT -MET 18772.62 2.22 11 428 
  18903.82   18773.32 ESI-TOF -MET 18772.62 -37.18     
  18903.82 SmRC 18773.17 ESI-FT -MET 18772.62 -28.97 7 344 
  18903.82   18773.79 ESI-TOF -MET 18772.62 -61.90     
                    
RplL 
L7/L12 12295.23 WT 12206.05 ESI-FT -MET, Ac 12206.06 1.11 10 778 
12295.23 12295.23   12133.78 ESI-TOF 
-MET, -SER, Ac, 
CH2 12133.01 -62.97     
  12295.23   12149.91 ESI-TOF 
-MET, -SER, Ac, 
2-Ox 12150.98 88.13     
  12295.23   12206.89 ESI-TOF -MET, Ac 12206.06 -67.32     
  12295.23   12221.71 ESI-TOF -MET, Ac, CH2 12220.09 -132.55     
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Sequence-
predicted 
Ave. Mass 
Calculated 
Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
Calculated 
Mass  
(plus PTM) 
Prediction 
Error      
(ppm) 
*Unique 
Peptides 
^Mascot 
MS & 
MS/MS 
Score 
  12295.23   12235.00 ESI-TOF -MET, Ac, 2-CH2 12234.12 -72.09     
  12295.23   12264.81 ESI-TOF 
-MET, Ac, 3-CH2, 
Ox 12264.14 -54.35     
  12295.23   12274.02 ESI-TOF 
-MET, Ac, CH2, 
2-Ox, Na 12274.07 4.56     
  12295.23   12296.25 ESI-TOF None 12295.23 -83.37     
  12295.23 SmR 12206.53 ESI-FT -MET, Ac 12206.06 -38.09 9 - 
  12295.23   12134.33 ESI-TOF 
-MET, -SER, Ac, 
Ox 12134.99 53.85     
  12295.23   12150.05 ESI-TOF 
-MET, -SER, Ac,  
2-Ox 12150.98 77.19     
  12295.23   12164.00 ESI-TOF -MET 12164.03 2.22     
  12295.23   12207.35 ESI-TOF -MET, Ac 12206.06 -105.50     
  12295.23   12221.14 ESI-TOF -MET, Ac, CH2 12220.09 -85.99     
  12295.23   12247.89 ESI-TOF -MET, Ac, 3-CH2 12248.15 21.06     
  12295.23   12264.60 ESI-TOF 
-MET, Ac, 3-CH2, 
Ox 12264.14 -37.15     
  12295.23   12273.26 ESI-TOF 
-Met, Ac, CH2,  
2-Ox, Na 12274.07 66.24     
  12295.23   12285.28 ESI-TOF 
-MET, Ac,  
3-CH2,Ox, Na 12286.08 65.36     
  12295.23   12297.85 ESI-TOF 
-Met, Ac,  
2-CH2,4-Ox 12298.12 21.79     
  12295.23 SmRC 12206.84 ESI-FT -MET, Ac 12206.06 -63.75 10 738 
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Sequence-
predicted 
Ave. Mass 
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Ave. Mass Derivative 
Experimental 
Mass  Source Predicted PTM 
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Mass  
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Prediction 
Error      
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*Unique 
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MS & 
MS/MS 
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  12295.23   12220.10 ESI-FT -MET, Ac, CH2 12220.09 -0.90     
  12295.23   12134.51 ESI-TOF 
-MET, -SER, Ac, 
Ox 12134.99 38.85     
  12295.23   12152.55 ESI-TOF 
-MET, -SER, CH2, 
2-Ox, Na 12151.96 -48.96     
  12295.23   12220.35 ESI-TOF -MET, Ac, CH2 12220.09 -20.93     
  12295.23   12298.48 ESI-TOF 
-Met, Ac, 2-
CH2,4-Ox 12298.12 -29.27     
                    
RplI L9 15769.09 WT 15769.28 ESI-TOF None 15769.09 -12.18 9 189 
15769.09 15769.09 SmR 15768.20 ESI-TOF None 15769.09 56.12 9 - 
  15769.09 SmRC 15770.68 ESI-TOF None 15769.09 -101.34 9 290 
                    
RplJ L10 17711.65 WT 17579.97 ESI-FT -MET 17580.45 27.06 5 403 
17711.65 17711.65   17581.35 ESI-TOF -MET 17580.45 -51.14     
  17711.65 SmR 17580.72 ESI-FT -MET 17580.45 -15.45 9 404 
  17711.65   17580.60 ESI-TOF -MET 17580.45 -8.59     
  17711.65 SmRC 17580.00 ESI-FT -MET 17580.45 25.69 5 277 
                    
          
RplK L11 14875.44 WT 14870.39 ESI-FT -MET, 9-CH2 14870.48 6.21 6 166 
14875.44 14875.44   14870.96 ESI-TOF -MET, 9-CH2 14870.48 -32.27     
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Ave. Mass Derivative 
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Mass  Source Predicted PTM 
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(ppm) 
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MS & 
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  14875.44   14840.02 ESI-TOF 
-MET, 3-CH2,  
2-Ox, Na 14840.26 15.84     
  14875.44   14889.26 ESI-TOF 
-MET, 7-CH2,  
3-Ox 14890.38 75.28     
  14875.44   14911.41 ESI-TOF -MET, 12-CH2 14912.56 77.10     
  14875.44   14936.35 ESI-TOF 2-CH2, 2-Ox 14935.49 -57.41     
  14875.44 SmR 14870.39 ESI-FT -MET, 9-CH2 14870.48 6.21 3 92 
  14875.44   14870.72 ESI-TOF -MET, 9-CH2 14870.48 -16.33     
  14875.44 SmRC 14870.62 ESI-FT -MET, 9-CH2 14870.48 -9.45 5 115 
  14875.44   14840.96 ESI-TOF 
-MET, 3-CH2,  
2-Ox, Na 14840.26 -47.51     
  14875.44   14870.41 ESI-TOF -MET, 9-CH2 14870.48 4.98     
  14875.44   14889.95 ESI-TOF 
-MET, 7-CH2,  
3-Ox 14890.38 29.21     
  14875.44   14911.79 ESI-TOF -MET, 12-CH2 14912.56 51.49     
  14875.44   14937.76 ESI-TOF 2-CH2, 2-Ox 14935.49 -152.21     
                    
RplM L13 16018.58 WT 16018.03 ESI-FT None 16018.58 34.59 4 201 
16018.58 16018.58   16018.55 ESI-TOF None 16018.58 2.37     
  16018.58 SmR 16017.87 ESI-FT None 16018.58 44.36 5 - 
  16018.58   16018.97 ESI-TOF None 16018.58 -24.35     
  16018.58 SmRC 16018.50 ESI-FT None 16018.58 5.46 4 310 
  16018.58   16018.83 ESI-TOF None 16018.58 -15.05     
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RplN L14 13541.08 WT 13540.55 ESI-FT None 13541.08 39.52 3 170 
13541.08 13541.08   13539.80 ESI-TOF None 13541.08 94.60     
  13541.08 SmR 13541.00 ESI-FT None 13541.08 5.85 4 178 
  13541.08   13538.87 ESI-TOF None 13541.08 163.28     
  13541.08   13541.58 ESI-TOF None 13541.08 -36.85     
  13541.08 SmRC 13540.93 ESI-FT None 13541.08 11.17 4 185 
  13541.08   13541.41 ESI-TOF None 13541.08 -24.07     
                    
RplO L15 14980.46 WT 14980.42 ESI-FT None 14980.46 2.32 5 164 
14980.46 14980.46   14981.92 ESI-TOF None 14980.46 -97.66     
  14980.46 SmR 14980.63 ESI-FT None 14980.46 -11.83 8 312 
  14980.46   14980.41 ESI-TOF None 14980.46 3.14     
  14980.46 SmRC 14980.31 ESI-FT None 14980.46 9.49 4 257 
  14980.46   14982.98 ESI-TOF None 14980.46 -168.29     
                    
RplP L16 15281.26 WT 15327.07 ESI-TOF CH2, 2-Ox 15327.28 13.88 4 126 
15281.26 15281.26   15311.60 ESI-TOF CH2, Ox 15311.28 -20.88     
  15281.26 SmR 15327.92 ESI-TOF CH2, 2-Ox 15327.28 -41.25 6 148 
  15281.26   15311.31 ESI-TOF CH2, Ox 15311.28 -1.68     
  15281.26 SmRC 15327.19 ESI-FT CH2, 2-Ox 15327.28 5.76 4 221 
  15281.26   15327.34 ESI-TOF CH2, 2-Ox 15327.28 -3.80     
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  15281.26   15311.72 ESI-TOF CH2, Ox 15311.28 -28.33     
                    
RplQ L17 14364.64 WT 14364.05 ESI-FT None 14364.64 40.56 5 176 
14364.64 14364.64 SmR 14365.07 ESI-TOF None 14364.64 -30.42 6 189 
  14364.64 SmRC 14365.26 ESI-FT None 14364.64 -43.11 5 202 
                    
RplR L18 12769.66 WT 12769.87 ESI-FT None 12769.66 -17.02 2 369 
12769.66 12769.66   12769.72 ESI-TOF None 12769.66 -5.09     
  12769.66 SmR 12770.35 ESI-FT None 12769.66 -54.70 2 - 
  12769.66   12769.65 ESI-TOF None 12769.66 0.39     
  12769.66 SmRC 12770.35 ESI-FT None 12769.66 -54.70 2 99 
  12769.66   12771.53 ESI-TOF None 12769.66 -146.44     
                    
RplS L19 13133.26 WT 13001.53 ESI-FT -MET 13002.06 40.78 4 276 
13133.26 13133.26   13002.02 ESI-TOF -MET 13002.06 3.38     
  13133.26 SmR 13002.41 ESI-FT -MET 13002.06 -26.56 4 79 
  13133.26   13002.16 ESI-TOF -MET 13002.06 -7.38     
  13133.26 SmRC 13002.20 ESI-FT -MET 13002.06 -10.53 4 257 
  13133.26   13002.96 ESI-TOF -MET 13002.06 -68.76     
                    
RplT L20 13496.99 WT 13365.42 ESI-TOF -MET 13365.79 27.38 6 73 
13496.99 13496.99 SmR 13365.48 ESI-FT -MET 13365.79 22.71 4 53 
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  13496.99   13366.01 ESI-TOF -MET 13365.79 -16.91     
  13496.99 SmRC 13365.53 ESI-FT -MET 13365.79 19.08 4 - 
  13496.99   13367.60 ESI-TOF -MET 13365.79 -135.79     
                    
RplU L21 11564.37 WT 11564.37 ESI-FT None 11564.37 0.51 5 - 
11564.37 11564.37   11564.74 ESI-TOF None 11564.37 -31.56     
  11564.37 SmR 11562.90 ESI-TOF None 11564.37 127.03 3 102 
  11564.37 SmRC 11564.49 ESI-FT None 11564.37 -10.34 5 93 
                    
RplV L22 12226.33 WT 12226.49 ESI-TOF None 12226.33 -13.58 7 134 
12226.33 12226.33 SmR 12226.63 ESI-TOF None 12226.33 -24.86 9 84 
  12226.33   12226.04 ESI-FT None 12226.33 23.58     
  12226.33 SmRC 12227.28 ESI-TOF None 12226.33 -77.95 6 140 
                    
RplW L23 11199.14 WT 11199.23 ESI-TOF None 11199.14 -7.50 3 - 
11199.14 11199.14 SmR 11199.29 ESI-TOF None 11199.14 -13.13 1 - 
  11199.14   11197.29 ESI-TOF None 11199.14 165.46     
  11199.14   11199.08 ESI-FT None 11199.14 5.76     
  11199.14 SmRC 11199.12 ESI-FT None 11199.14 2.27 4 - 
  11199.14   11198.52 ESI-TOF None 11199.14 55.63     
                    
RplX L24 11316.23 WT 11185.06 ESI-FT -MET 11185.03 -2.43 8 377 
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11316.23 11316.23   11185.18 ESI-TOF -MET 11185.03 -13.41     
  11316.23 SmR 11185.05 ESI-FT -MET 11185.03 -1.01 8 301 
  11316.23   11185.28 ESI-TOF -MET 11185.03 -21.99     
  11316.23 SmRC 11185.03 ESI-FT -MET 11185.03 -0.06 7 478 
  11316.23   11186.08 ESI-TOF -MET 11185.03 -93.25     
                    
RplY L25 10693.47 WT 10693.45 ESI-FT None 10693.47 1.98 8 176 
10693.47 10693.47   10693.48 ESI-TOF None 10693.47 -0.56     
  10693.47 SmR 10693.45 ESI-FT None 10693.47 1.68 2 - 
  10693.47   10693.65 ESI-TOF None 10693.47 -16.55     
  10693.47   10693.20 ESI-TOF None 10693.47 25.34     
  10693.47 SmRC 10693.35 ESI-FT None 10693.47 11.36 8 194 
  10693.47   10694.29 ESI-TOF None 10693.47 -76.96     
                    
RpmA L27 9124.49 WT 8993.04 ESI-FT -MET 8993.30 28.48 2 420 
9124.49 9124.49 SmR 8993.45 ESI-FT -MET 8993.30 -16.73 2 309 
  9124.49   8993.60 ESI-TOF -MET 8993.30 -33.36     
  9124.49 SmRC 8993.27 ESI-FT -MET 8993.30 2.56 1 130 
                    
RpmB L28 9006.52 WT 8874.79 ESI-FT -MET 8875.32 59.17 1 265 
9006.52 9006.52 SmR 8875.31 ESI-TOF -MET 8875.32 0.68 1 299 
  9006.52 SmRC 8875.42 ESI-FT -MET 8875.32 -11.80 1 282 
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RpmC L29 7273.47 WT 7273.22 ESI-FT None 7273.47 34.79 3 245 
7273.47 7273.47   7273.29 ESI-TOF None 7273.47 24.34     
  7273.47 SmR 7272.76 ESI-FT None 7273.47 97.26 1 135 
  7273.47   7273.56 ESI-TOF None 7273.47 -12.65     
  7273.47 SmRC 7273.49 ESI-FT None 7273.47 -2.85 3 141 
  7273.47   7274.33 ESI-TOF None 7273.47 -117.83     
                    
RpmD L30 6541.82 WT 6410.17 ESI-FT -MET 6410.62 69.73 2 104 
6541.82 6541.82   6410.62 ESI-TOF -MET 6410.62 -0.16     
  6541.82 SmR 6410.31 ESI-FT -MET 6410.62 47.66 1 - 
  6541.82   6410.45 ESI-TOF -MET 6410.62 25.89     
  6541.82 SmRC 6410.67 ESI-FT -MET 6410.62 -7.65 2 95 
  6541.82   6411.74 ESI-TOF -MET 6410.62 -175.49     
                    
RpmE L31 7871.11 WT 7871.26 ESI-FT None 7871.11 -19.82 0 74 
7871.11 7871.11   7869.20 ESI-TOF None 7871.11 242.41     
  7871.11 SmR 7871.05 ESI-FT None 7871.11 7.20 0 - 
  7871.11   7869.26 ESI-TOF None 7871.11 235.16     
  7871.11 SmRC Not Observed         1 62 
                    
RpmF L32 6446.40 WT 6314.68 ESI-FT -MET 6315.20 82.79 1 382 
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6446.40 6446.40 SmR 6314.65 ESI-FT -MET 6315.20 87.27 3 - 
  6446.40   6314.62 ESI-TOF -MET 6315.20 92.63     
  6446.40 SmRC 6314.65 ESI-FT -MET 6315.20 87.27 2 - 
                    
RpmG 
L33 6371.60 WT 6254.57 ESI-FT -MET, CH2 6254.42 -23.59 1 387 
6371.60 6371.60   6239.70 ESI-TOF -MET 6240.40 112.81     
  6371.60   6254.21 ESI-TOF -MET, CH2 6254.42 34.04     
  6371.60   6267.80 ESI-TOF -MET, 2-CH2 6268.45 103.82     
  6371.60 SmR 6254.32 ESI-FT -MET, CH2 6254.42 16.87 1 223 
  6371.60   6238.60 ESI-TOF -MET 6240.40 289.08     
  6371.60   6254.24 ESI-TOF -MET, CH2 6254.42 29.08     
  6371.60   6268.12 ESI-TOF -MET, 2-CH2 6268.45 52.45     
  6371.60 SmRC 6254.45 ESI-FT -MET, CH2 6254.42 -3.62 1 211 
  6371.60   6240.80 ESI-TOF -MET 6240.40 -63.46     
  6371.60   6254.96 ESI-TOF -MET, CH2 6254.42 -85.24     
  6371.60   6268.00 ESI-TOF -MET, 2-CH2 6268.45 71.92     
                    
RpmH 
L34 5380.41 WT Not Observed         0 281 
5380.41 5380.41 SmR Not Observed           - 
  5380.41 SmRC Not Observed           - 
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RpmI L35 7288.96 WT 7157.32 ESI-FT -MET 7157.76 61.47 0 38 
7288.96 7288.96   7157.58 ESI-TOF -MET 7157.76 25.29     
  7288.96 SmR 7157.99 ESI-TOF -MET 7157.76 -31.71   - 
  7288.96 SmRC Not Observed           - 
                    
RpmJ L36 4364.36 WT 4362.77 ESI-TOF None 4364.45 385.98 0 25 
4364.36 4364.36 SmR 4363.27 ESI-TOF None 4364.45 271.42   42 
  4364.36   4363.79 ESI-TOF None 4364.45 152.28     
  4364.36   4364.72 ESI-FT None 4364.45 -60.05     
  4364.36 SmRC 4313.78 ESI-TOF unknown - -   - 
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Table A1 - Summary of top-down/bottom-up MS protein analyses. Summary of ribosomal protein identifications and PTM 
isoforms predicted in the combined top-down/bottom-up analysis of E. coli ribosomal proteins showing FT-ICR generated (green) and 
BioTOFII generated (orange) data. *Unique peptides observed in the bottom-up (shotgun) datasets. ^Mascot MS and MS/MS scores 
from the analysis of MALDI MS/MS datasets.  
 
